ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

Information

  • Patent Application
  • 20240206315
  • Publication Number
    20240206315
  • Date Filed
    February 12, 2024
    9 months ago
  • Date Published
    June 20, 2024
    4 months ago
Abstract
Novel ligands for metal complexes containing five-membered ring fused on pyrimidine ring combined with partially fluorinated side chains exhibiting improved external quantum efficiency and lifetime are disclosed.
Description
PARTIES TO A JOINT RESEARCH AGREEMENT

The claimed invention was made by, on behalf of, and/or in connection with one or more of the following parties to a joint university corporation research agreement: The Regents of the University of Michigan, Princeton University, University of Southern California, and the Universal Display Corporation. The agreement was in effect on and before the date the claimed invention was made, and the claimed invention was made as a result of activities undertaken within the scope of the agreement.


FIELD OF THE INVENTION

The present invention relates to compounds for use as emitters, and devices, such as organic light emitting diodes, including the same.


BACKGROUND

Opto-electronic devices that make use of organic materials are becoming increasingly desirable for a number of reasons. Many of the materials used to make such devices are relatively inexpensive, so organic opto-electronic devices have the potential for cost advantages over inorganic devices. In addition, the inherent properties of organic materials, such as their flexibility, may make them well suited for particular applications such as fabrication on a flexible substrate. Examples of organic opto-electronic devices include organic light emitting diodes/devices (OLEDs), organic phototransistors, organic photovoltaic cells, and organic photodetectors. For OLEDs, the organic materials may have performance advantages over conventional materials. For example, the wavelength at which an organic emissive layer emits light may generally be readily tuned with appropriate dopants.


OLEDs make use of thin organic films that emit light when voltage is applied across the device. OLEDs are becoming an increasingly interesting technology for use in applications such as flat panel displays, illumination, and backlighting. Several OLED materials and configurations are described in U.S. Pat. Nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated herein by reference in their entirety.


One application for phosphorescent emissive molecules is a full color display. Industry standards for such a display call for pixels adapted to emit particular colors, referred to as “saturated” colors. In particular, these standards call for saturated red, green, and blue pixels. Alternatively the OLED can be designed to emit white light. In conventional liquid crystal displays emission from a white backlight is filtered using absorption filters to produce red, green and blue emission. The same technique can also be used with OLEDs. The white OLED can be either a single EML device or a stack structure. Color may be measured using CIE coordinates, which are well known to the art.


One example of a green emissive molecule is tris(2-phenylpyridine) iridium, denoted Ir(ppy)3, which has the following structure:




embedded image


In this, and later figures herein, we depict the dative bond from nitrogen to metal (here, Ir) as a straight line.


As used herein, the term “organic” includes polymeric materials as well as small molecule organic materials that may be used to fabricate organic opto-electronic devices. “Small molecule” refers to any organic material that is not a polymer, and “small molecules” may actually be quite large. Small molecules may include repeat units in some circumstances. For example, using a long chain alkyl group as a substituent does not remove a molecule from the “small molecule” class. Small molecules may also be incorporated into polymers, for example as a pendent group on a polymer backbone or as a part of the backbone. Small molecules may also serve as the core moiety of a dendrimer, which consists of a series of chemical shells built on the core moiety. The core moiety of a dendrimer may be a fluorescent or phosphorescent small molecule emitter. A dendrimer may be a “small molecule,” and it is believed that all dendrimers currently used in the field of OLEDs are small molecules.


As used herein, “top” means furthest away from the substrate, while “bottom” means closest to the substrate. Where a first layer is described as “disposed over” a second layer, the first layer is disposed further away from substrate. There may be other layers between the first and second layer, unless it is specified that the first layer is “in contact with” the second layer. For example, a cathode may be described as “disposed over” an anode, even though there are various organic layers in between.


As used herein, “solution processible” means capable of being dissolved, dispersed, or transported in and/or deposited from a liquid medium, either in solution or suspension form.


A ligand may be referred to as “photoactive” when it is believed that the ligand directly contributes to the photoactive properties of an emissive material. A ligand may be referred to as “ancillary” when it is believed that the ligand does not contribute to the photoactive properties of an emissive material, although an ancillary ligand may alter the properties of a photoactive ligand.


As used herein, and as would be generally understood by one skilled in the art, a first “Highest Occupied Molecular Orbital” (HOMO) or “Lowest Unoccupied Molecular Orbital” (LUMO) energy level is “greater than” or “higher than” a second HOMO or LUMO energy level if the first energy level is closer to the vacuum energy level. Since ionization potentials (IP) are measured as a negative energy relative to a vacuum level, a higher HOMO energy level corresponds to an IP having a smaller absolute value (an IP that is less negative). Similarly, a higher LUMO energy level corresponds to an electron affinity (EA) having a smaller absolute value (an EA that is less negative). On a conventional energy level diagram, with the vacuum level at the top, the LUMO energy level of a material is higher than the HOMO energy level of the same material. A “higher” HOMO or LUMO energy level appears closer to the top of such a diagram than a “lower” HOMO or LUMO energy level.


As used herein, and as would be generally understood by one skilled in the art, a first work function is “greater than” or “higher than” a second work function if the first work function has a higher absolute value. Because work functions are generally measured as negative numbers relative to vacuum level, this means that a “higher” work function is more negative. On a conventional energy level diagram, with the vacuum level at the top, a “higher” work function is illustrated as further away from the vacuum level in the downward direction. Thus, the definitions of HOMO and LUMO energy levels follow a different convention than work functions.


More details on OLEDs, and the definitions described above, can be found in U.S. Pat. No. 7,279,704, which is incorporated herein by reference in its entirety.


SUMMARY

According to some embodiments of the present disclosure, a heteroleptic compound having a formula Ir(LA)n(LB)3−n is disclosed. In the formula Ir(LA)n(LB)3−n,

    • the ligand LA is




embedded image




    • the ligand LB is







embedded image




    • LA is a different ligand from LB;

    • n is 1 or 2;

    • rings A, C, and D are each independently a 5-membered or 6-membered carbocyclic or heterocyclic ring;

    • RA, RC, and RD each independently represent mono, di, tri, or tetra-substitution, or no substitution;

    • RB represents mono, di, tri, or tetra-substitution;

    • at least one RB has the following structure:







embedded image




    • wherein X1, X2, X3, X4, and X5 are each independently carbon or nitrogen;

    • wherein RA, RB, RC, RD, RX, RY, and RZ are each independently selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and any two adjacent substituents are optionally joined or fused into a ring;

    • wherein R1, and R2 are each independently selected from the group consisting of alkyl, cycloalkyl, partially fluorinated alkyl, partially fluorinated cycloalkyl, and their partially detuerated or fully deuterated analogs, and combinations thereof;

    • wherein in each of the R1, and R2, if a carbon has a fluorine atom attached thereto, then said carbon is separated by at least one carbon atom from the ring E; and

    • wherein R1 and R2 are each attached to the ring E by a carbon that is a primary, secondary, tertiary, or a quaternary carbon.





According to another aspect of the present disclosure, a first organic light emitting device incorporating the heteroleptic compound is disclosed.


According to some embodiments, a formulation comprising the heteroleptic compound is also disclosed.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows an organic light emitting device.



FIG. 2 shows an inverted organic light emitting device that does not have a separate electron transport layer.





DETAILED DESCRIPTION

Generally, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When a current is applied, the anode injects holes and the cathode injects electrons into the organic layer(s). The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and hole localize on the same molecule, an “exciton,” which is a localized electron-hole pair having an excited energy state, is formed. Light is emitted when the exciton relaxes via a photoemissive mechanism. In some cases, the exciton may be localized on an excimer or an exciplex. Non-radiative mechanisms, such as thermal relaxation, may also occur, but are generally considered undesirable.


The initial OLEDs used emissive molecules that emitted light from their singlet states (“fluorescence”) as disclosed, for example, in U.S. Pat. No. 4,769,292, which is incorporated by reference in its entirety. Fluorescent emission generally occurs in a time frame of less than 10 nanoseconds.


More recently, OLEDs having emissive materials that emit light from triplet states (“phosphorescence”) have been demonstrated. Baldo et al., “Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices,” Nature, vol. 395, 151-154, 1998; (“Baldo-I”) and Baldo et al., “Very high-efficiency green organic light-emitting devices based on electrophosphorescence,” Appl. Phys. Lett., vol. 75, No. 3, 4-6 (1999) (“Baldo-II”), are incorporated by reference in their entireties. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704 at cols. 5-6, which are incorporated by reference.



FIG. 1 shows an organic light emitting device 100. The figures are not necessarily drawn to scale. Device 100 may include a substrate 110, an anode 115, a hole injection layer 120, a hole transport layer 125, an electron blocking layer 130, an emissive layer 135, a hole blocking layer 140, an electron transport layer 145, an electron injection layer 150, a protective layer 155, a cathode 160, and a barrier layer 170. Cathode 160 is a compound cathode having a first conductive layer 162 and a second conductive layer 164. Device 100 may be fabricated by depositing the layers described, in order. The properties and functions of these various layers, as well as example materials, are described in more detail in U.S. Pat. No. 7,279,704 at cols. 6-10, which are incorporated by reference.


More examples for each of these layers are available. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is m-MTDATA doped with F4-TCNQ at a molar ratio of 50:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of emissive and host materials are disclosed in U.S. Pat. No. 6,303,238 to Thompson et al., which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entireties, disclose examples of cathodes including compound cathodes having a thin layer of metal such as Mg:Ag with an overlying transparent, electrically-conductive, sputter-deposited ITO layer. The theory and use of blocking layers is described in more detail in U.S. Pat. No. 6,097,147 and U.S. Patent Application Publication No. 2003/0230980, which are incorporated by reference in their entireties. Examples of injection layers are provided in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of protective layers may be found in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety.



FIG. 2 shows an inverted OLED 200. The device includes a substrate 210, a cathode 215, an emissive layer 220, a hole transport layer 225, and an anode 230. Device 200 may be fabricated by depositing the layers described, in order. Because the most common OLED configuration has a cathode disposed over the anode, and device 200 has cathode 215 disposed under anode 230, device 200 may be referred to as an “inverted” OLED. Materials similar to those described with respect to device 100 may be used in the corresponding layers of device 200. FIG. 2 provides one example of how some layers may be omitted from the structure of device 100.


The simple layered structure illustrated in FIGS. 1 and 2 is provided by way of non-limiting example, and it is understood that embodiments of the invention may be used in connection with a wide variety of other structures. The specific materials and structures described are exemplary in nature, and other materials and structures may be used. Functional OLEDs may be achieved by combining the various layers described in different ways, or layers may be omitted entirely, based on design, performance, and cost factors. Other layers not specifically described may also be included. Materials other than those specifically described may be used. Although many of the examples provided herein describe various layers as comprising a single material, it is understood that combinations of materials, such as a mixture of host and dopant, or more generally a mixture, may be used. Also, the layers may have various sublayers. The names given to the various layers herein are not intended to be strictly limiting. For example, in device 200, hole transport layer 225 transports holes and injects holes into emissive layer 220, and may be described as a hole transport layer or a hole injection layer. In one embodiment, an OLED may be described as having an “organic layer” disposed between a cathode and an anode. This organic layer may comprise a single layer, or may further comprise multiple layers of different organic materials as described, for example, with respect to FIGS. 1 and 2.


Structures and materials not specifically described may also be used, such as OLEDs comprised of polymeric materials (PLEDs) such as disclosed in U.S. Pat. No. 5,247,190 to Friend et al., which is incorporated by reference in its entirety. By way of further example, OLEDs having a single organic layer may be used. OLEDs may be stacked, for example as described in U.S. Pat. No. 5,707,745 to Forrest et al, which is incorporated by reference in its entirety. The OLED structure may deviate from the simple layered structure illustrated in FIGS. 1 and 2. For example, the substrate may include an angled reflective surface to improve out-coupling, such as a mesa structure as described in U.S. Pat. No. 6,091,195 to Forrest et al., and/or a pit structure as described in U.S. Pat. No. 5,834,893 to Bulovic et al., which are incorporated by reference in their entireties.


Unless otherwise specified, any of the layers of the various embodiments may be deposited by any suitable method. For the organic layers, preferred methods include thermal evaporation, ink-jet, such as described in U.S. Pat. Nos. 6,013,982 and 6,087,196, which are incorporated by reference in their entireties, organic vapor phase deposition (OVPD), such as described in U.S. Pat. No. 6,337,102 to Forrest et al., which is incorporated by reference in its entirety, and deposition by organic vapor jet printing (OVJP), such as described in U.S. Pat. No. 7,431,968, which is incorporated by reference in its entirety. Other suitable deposition methods include spin coating and other solution based processes. Solution based processes are preferably carried out in nitrogen or an inert atmosphere. For the other layers, preferred methods include thermal evaporation. Preferred patterning methods include deposition through a mask, cold welding such as described in U.S. Pat. Nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entireties, and patterning associated with some of the deposition methods such as ink-jet and OVJD. Other methods may also be used. The materials to be deposited may be modified to make them compatible with a particular deposition method. For example, substituents such as alkyl and aryl groups, branched or unbranched, and preferably containing at least 3 carbons, may be used in small molecules to enhance their ability to undergo solution processing. Substituents having 20 carbons or more may be used, and 3-20 carbons is a preferred range. Materials with asymmetric structures may have better solution processability than those having symmetric structures, because asymmetric materials may have a lower tendency to recrystallize. Dendrimer substituents may be used to enhance the ability of small molecules to undergo solution processing.


Devices fabricated in accordance with embodiments of the present invention may further optionally comprise a barrier layer. One purpose of the barrier layer is to protect the electrodes and organic layers from damaging exposure to harmful species in the environment including moisture, vapor and/or gases, etc. The barrier layer may be deposited over, under or next to a substrate, an electrode, or over any other parts of a device including an edge. The barrier layer may comprise a single layer, or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include compositions having a single phase as well as compositions having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate an inorganic or an organic compound or both. The preferred barrier layer comprises a mixture of a polymeric material and a non-polymeric material as described in U.S. Pat. No. 7,968,146, PCT Pat. Application Nos. PCT/US2007/023098 and PCT/US2009/042829, which are herein incorporated by reference in their entireties. To be considered a “mixture”, the aforesaid polymeric and non-polymeric materials comprising the barrier layer should be deposited under the same reaction conditions and/or at the same time. The weight ratio of polymeric to non-polymeric material may be in the range of 95:5 to 5:95. The polymeric material and the non-polymeric material may be created from the same precursor material. In one example, the mixture of a polymeric material and a non-polymeric material consists essentially of polymeric silicon and inorganic silicon.


Devices fabricated in accordance with embodiments of the invention can be incorporated into a wide variety of electronic component modules (or units) that can be incorporated into a variety of electronic products or intermediate components. Examples of such electronic products or intermediate components include display screens, lighting devices such as discrete light source devices or lighting panels, etc. that can be utilized by the end-user product manufacturers. Such electronic component modules can optionally include the driving electronics and/or power source(s). Devices fabricated in accordance with embodiments of the invention can be incorporated into a wide variety of consumer products that have one or more of the electronic component modules (or units) incorporated therein. Such consumer products would include any kind of products that include one or more light source(s) and/or one or more of some type of visual displays. Some examples of such consumer products include flat panel displays, computer monitors, medical monitors, televisions, billboards, lights for interior or exterior illumination and/or signaling, heads-up displays, fully or partially transparent displays, flexible displays, laser printers, telephones, cell phones, tablets, phablets, personal digital assistants (PDAs), wearable device, laptop computers, digital cameras, camcorders, viewfinders, micro-displays, 3-D displays, vehicles, a large area wall, theater or stadium screen, or a sign. Various control mechanisms may be used to control devices fabricated in accordance with the present invention, including passive matrix and active matrix. Many of the devices are intended for use in a temperature range comfortable to humans, such as 18 degrees C. to 30 degrees C., and more preferably at room temperature (20-25 degrees C.), but could be used outside this temperature range, for example, from −40 degree C. to +80 degree C.


The materials and structures described herein may have applications in devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may employ the materials and structures. More generally, organic devices, such as organic transistors, may employ the materials and structures.


The term “halo,” “halogen,” or “halide” as used herein includes fluorine, chlorine, bromine, and iodine.


The term “alkyl” as used herein contemplates both straight and branched chain alkyl radicals. Preferred alkyl groups are those containing from one to fifteen carbon atoms and includes methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, and the like. Additionally, the alkyl group may be optionally substituted.


The term “cycloalkyl” as used herein contemplates cyclic alkyl radicals. Preferred cycloalkyl groups are those containing 3 to 10 ring carbon atoms and includes cyclopropyl, cyclopentyl, cyclohexyl, adamantyl, and the like. Additionally, the cycloalkyl group may be optionally substituted.


The term “alkenyl” as used herein contemplates both straight and branched chain alkene radicals. Preferred alkenyl groups are those containing two to fifteen carbon atoms. Additionally, the alkenyl group may be optionally substituted.


The term “alkynyl” as used herein contemplates both straight and branched chain alkyne radicals. Preferred alkynyl groups are those containing two to fifteen carbon atoms. Additionally, the alkynyl group may be optionally substituted.


The terms “aralkyl” or “arylalkyl” as used herein are used interchangeably and contemplate an alkyl group that has as a substituent an aromatic group. Additionally, the aralkyl group may be optionally substituted.


The term “heterocyclic group” as used herein contemplates aromatic and non-aromatic cyclic radicals. Hetero-aromatic cyclic radicals also means heteroaryl. Preferred hetero-non-aromatic cyclic groups are those containing 3 to 7 ring atoms which includes at least one hetero atom, and includes cyclic amines such as morpholino, piperdino, pyrrolidino, and the like, and cyclic ethers, such as tetrahydrofuran, tetrahydropyran, and the like. Additionally, the heterocyclic group may be optionally substituted.


The term “aryl” or “aromatic group” as used herein contemplates single-ring groups and polycyclic ring systems. The polycyclic rings may have two or more rings in which two carbons are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is aromatic, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. Preferred aryl groups are those containing six to thirty carbon atoms, preferably six to twenty carbon atoms, more preferably six to twelve carbon atoms. Especially preferred is an aryl group having six carbons, ten carbons or twelve carbons. Suitable aryl groups include phenyl, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene, preferably phenyl, biphenyl, triphenyl, triphenylene, fluorene, and naphthalene. Additionally, the aryl group may be optionally substituted.


The term “heteroaryl” as used herein contemplates single-ring hetero-aromatic groups that may include from one to five heteroatoms. The term heteroaryl also includes polycyclic hetero-aromatic systems having two or more rings in which two atoms are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is a heteroaryl, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. Preferred heteroaryl groups are those containing three to thirty carbon atoms, preferably three to twenty carbon atoms, more preferably three to twelve carbon atoms. Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine, preferably dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, triazine, benzimidazole, 1,2-azaborine, 1,3-azaborine, 1,4-azaborine, borazine, and aza-analogs thereof. Additionally, the heteroaryl group may be optionally substituted.


The alkyl, cycloalkyl, alkenyl, alkynyl, aralkyl, heterocyclic group, aryl, and heteroaryl may be unsubstituted or may be substituted with one or more substituents selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, cyclic amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.


As used herein, “substituted” indicates that a substituent other than H is bonded to the relevant position, such as carbon. Thus, for example, where R1 is mono-substituted, then one R1 must be other than H. Similarly, where R1 is di-substituted, then two of R1 must be other than H. Similarly, where R1 is unsubstituted, R1 is hydrogen for all available positions.


The “aza” designation in the fragments described herein, i.e. aza-dibenzofuran, aza-dibenzothiophene, etc. means that one or more of the C—H groups in the respective fragment can be replaced by a nitrogen atom, for example, and without any limitation, azatriphenylene encompasses both dibenzo[f,h]quinoxaline and dibenzo[f,h]quinoline. One of ordinary skill in the art can readily envision other nitrogen analogs of the aza-derivatives described above, and all such analogs are intended to be encompassed by the terms as set forth herein.


It is to be understood that when a molecular fragment is described as being a substituent or otherwise attached to another moiety, its name may be written as if it were a fragment (e.g. phenyl, phenylene, naphthyl, dibenzofuryl) or as if it were the whole molecule (e.g. benzene, naphthalene, dibenzofuran). As used herein, these different ways of designating a substituent or attached fragment are considered to be equivalent.


Disclosed herein are heteroleptic phosphorescent metal complexes containing ligands based on a combination of phenyl pyridine combined with triazine moieties. The triazine units have aliphatic substituents. The addition of triazine groups on the backbone provides a red shift of the related light-emitting metal complex. This is due to the highly electron withdrawing effect of the triazine. The addition of aliphatic side chains on the triazine provides better external quantum efficiency (EQE) of the metal complex and better thermal stability.


According to an aspect of the present disclosure, a heteroleptic compound having a formula Ir(LA)n(LB)3−n is disclosed,

    • wherein the ligand LA is




embedded image




    • wherein the ligand LB is







embedded image




    • wherein LA is a different ligand from LB;

    • wherein n is 1 or 2;

    • wherein rings A, C, and D are each independently a 5-membered or 6-membered carbocyclic or heterocyclic ring;

    • wherein RA, RC, and RD each independently represent mono, di, tri, or tetra-substitution, or no substitution;

    • wherein RB represents mono, di, tri, or tetra-substitution;

    • wherein at least one RB has the following structure:







embedded image




    • wherein X1, X2, X3, X4, and X5 are each independently carbon or nitrogen;

    • wherein RA, RB, RC, RD, RX, RY, and RZ are each independently selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and any two adjacent substituents are optionally joined or fused into a ring;

    • wherein R1, and R2 are each independently selected from the group consisting of alkyl, cycloalkyl, partially fluorinated alkyl, partially fluorinated cycloalkyl, and their partially deuterated or fully deuterated analogs, and combinations thereof;

    • wherein in each of the R1, and R2, if a carbon has a fluorine atom attached thereto, then said carbon is separated by at least one carbon atom from the ring E; and

    • wherein R1 and R2 are each attached to the ring E by a carbon that is a primary, secondary, tertiary, or a quaternary carbon.





According to some embodiments of the heteroleptic compound having the formula Ir(LA)n(LB)3−n, ring A is benzene.


According to some embodiments of the heteroleptic compound having the formula Ir(LA)n(LB)3−n, ring C is benzene, and ring D is pyridine of which X5 is nitrogen.


According to some embodiments of the heteroleptic compound having the formula Ir(LA)n(LB)3−n, X1, X2, X3, and X4 are each a carbon.


According to some embodiments of the heteroleptic compound having the formula Ir(LA)n(LB)3−n, RB is para to the nitrogen coordinated to Ir.


According to some embodiments of the heteroleptic compound having the formula Ir(LA)n(LB)3−n, RB is meta to the nitrogen coordinated to Ir.


According to some embodiments of the heteroleptic compound having the formula Ir(LA)n(LB)3−n, R1 and R2 are each independently selected from the group consisting of methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, t-butyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, cyclobutyl, cyclopentyl, cyclohexyl, partially or fully deuterated variants thereof, partially fluorinated variants thereof, and combinations thereof.


According to some embodiments of the heteroleptic compound having the formula Ir(LA)n(LB)3−n, at least one of R1 and R2 is selected from the group consisting of:




embedded image


embedded image


embedded image


embedded image


According to some embodiments of the heteroleptic compound having the formula Ir(LA)n(LB)3−n, the ligand LA is selected from the group consisting of:














LA1 to LA11 represented by







embedded image







wherein in LA1: R1 = R2 = RB1,


in LA2: R1 = R2 = BB2,


in LA3: R1 = R2 = RB3,


in LA4: R1 = R2 = RB4,


in LA5: R1 = R2 = RB5,


in LA6: R1 = R2 = RB6,


in LA7: R1 = R2 = RB7,


in LA8: R1 = R2 = RB8,


in LA9: R1 = R2 = RA2,


in LA10: R1 = R2 = RA22, and


in LA11: R1 = R2 = RA28:,


LA12 to LA20 represented by







embedded image







wherein in LA12: R1 = RB2 and R2 = RB1,


in LA13: R1 = RB3 and R2 = RB1,


in LA14: R1 = RB5 and R2 = RB1,


in LA15: R1 = RA2 and R2 = RB1,


in LA16: R1 = RA28 and R2 = RB1,


in LA17: R1 = RB3 and R2 = RB2,


in LA18: R1 = RB5 and R2 = RB2,


in LA19: R1 = RA2 and R2 = RB2, and


in LA20: R1 = RA28 and R2 = RB2;,


LA21 to LA31 represented by







embedded image







wherein in LA21: R1 = R2 = RB1,


in LA22: R1 = R2 = RB2,


in LA23: R1 = R2 = RB3,


in LA24: R1 = R2 = RB4,


in LA25: R1 = R2 = RB5,


in LA26: R1 = R2 = RB6,


in LA27: R1 = R2 = RB7,


in LA28: R1 = R2 = RB8,


in LA29: R1 = R2 = RA2,


in LA30: R1 = R2 = RA22, and


in LA31: R1 = R2 = RA28;,


LA32 to LA42 represented by







embedded image







wherein in LA32: R1 = R2 = RB1,


in LA33: R1 = R2 = RB2,


in LA34: R1 = R2 = RB3,


in LA35: R1 = R2 = RB4,


in LA36: R1 = R2 = RB5,


in LA37: R1 = R2 = RB6,


in LA38: R1 = R2 = RB7,


in LA39: R1 = R2 = RB8,


in LA40: R1 = R2 = RA2,


in LA41: R1 = R2 = RA22, and


in LA42: R1 = R2 = RA28;,


LA43 to LA51 represented by







embedded image







wherein in LA43: R1 = RB2 and R2 = RB1,


in LA44: R1 = RB3 and R2 = RB1,


in LA45: R1 = RB5 and R2 = RB1,


in LA46: R1 = RA2 and R2 = RB1,


in LA47: R1 = RA28 and R2 = RB1,


in LA48: R1 = RB3 and R2 = RB2,


in LA49: R1 = RB5 and R2 = RB2,


in LA50: R1 = RA2 and R2 = RB2, and


in LA51: R1 = RA28 and R2 = RB2;,


LA52 to LA62 represented by







embedded image







wherein in LA52: R1 = R2 = RB1,


in LA53: R1 = R2 = BB2,


in LA54: R1 = R2 = RB3,


in LA55: R1 = R2 = RB4,


in LA56: R1 = R2 = RB5,


in LA57: R1 = R2 = RB6,


in LA58: R1 = R2 = RB7,


in LA59: R1 = R2 = RB8,


in LA60: R1 = R2 = RA2,


in LA61: R1 = R2 = RA22, and


in LA62: R1 = R2 = RA28;,


LA63 to LA71 represented by







embedded image







wherein in LA63: R1 = RB2 and R2 = RB1,


in LA64: R1 = RB3 and R2 = RB1,


in LA65: R1 = RB5and R2 = RB1,


in LA66: R1 = RA2 and R2 = RB1,


in LA67: R1 = RA28 and R2 = RB1,


in LA68: R1 = RB3 and R2 = RB2,


in LA69: R1 = RB5 and R2 = RB2,


in LA70: R1 = RA2 and R2 = RB2, and


in LA71: R2 = RA28 and R2 = RB2;,


LA72 to LA82 represented by







embedded image







wherein in LA72: R1 = R2 = RB1,


in LA73: R1 = R2 = RB2,


in LA74: R1 = R2 = RB3,


in LA75: R1 = R2 = RB4,


in LA76: R1 = R2 = RB5,


in LA77: R1 = R2 = RB6,


in LA78: R1 = R2 = RB7,


in LA79: R1 = R2 = RB8,


in LA80: R1 = R2 = RA2,


in LA81: R1 = R2 = RA22, and


in LA82: R1 = R2 = RA28;,


LA83 to L93 represented by







embedded image







wherein in LA83: R1 = R2 = RB1,


in LA84: R1 = R2 = RB2,


in LA85: R1 = R2 = RB3,


in LA86: R1 = R2 = RB4,


in LA87: R1 = R2 = RB5,


in LA88: R1 = R2 = RB6,


in LA89: R1 = R2 = RB7,


in LA90: R1 = R2 = RB8,


in LA91: R1 = R2 = RA2,


in LA92: R1 = R2 = RA22, and


in LA93: R1 = R2 = RA28;,


LA94 to LA102 represented by







embedded image







wherein in LA94: R1 = RB2 and R2 = RB1,


in LA95: R1 = RB3 and R2 = RB1,


in LA96: R1 = RB5 and R2 = RB1,


in LA97: R1 = RA2 and R2 = RB1,


in LA98: R1 = RA28 and R2 = RB1,


in LA99: R1 = RB3 and R2 = RB2,


in LA100: R1 = RB5 and R2 = RB2,


in LA101: R1 = RA2 and R2 = RB2, and


in LA102: R1 = RA28 and R2 = RB2;,


LA103 to LA113 represented by







embedded image







wherein in LA103: R1 = R2 = RB1,


in LA104: R1 = R2 = RB2,


in LA105: R1 = R2 = RB3,


in LA106: R1 = R2 = RB4,


in LA107: R1 = R2 = RB5,


in LA108: R1 = R2 = RB6,


in LA109: R1 = R2 = RB7,


in LA110: R1 = R2 = RB8,


in LA111: R1 = R2 = RA2,


in LA112: R1 = R2 = RA22, and


in LA113: R1 = R2 = RA28;,


LA114 to LA124 represented by







embedded image







wherein in LA114: R1 = R2 = RB1,


in LA115: R1 = R2 = RB2,


in LA116: R1 = R2 = RB3,


in LA117: R1 = R2 = RB4,


in LA118: R1 = R2 = RB5,


in LA119: R1 = R2 = RB6,


in LA120: R1 = R2 = RB7,


in LA121: R1 = R2 = RB8,


in LA122: R1 = R2 = RA2,


in LA123: R1 = R2 = RA22, and


in LA124: R1 = R2 = RA28;,


LA125 to LA133 represented by







embedded image







wherein in LA125: R1 = RB2 and R2 = RB1,


in LA126: R1 = RB3 and R2 = RB1,


in LA127: R1 = RB5 and R2 = RB1,


in LA128: R1 = RA2 and R2 = RB1,


in LA129: R1 = RA28 and R2 = RB1,


in LA130: R1 = RB3 and R2 = RB2,


in LA131: R1 = RB5 and R2 = RB2,


in LA132: R1 = RA2 and R2 = RB2, and


in LA133: R1 = RA28 and R2 = RB2;,


LA134 to LA144 represented by







embedded image







wherein in L134: R1 = R2 = RB1,


in LA135: R1 = R2 = RB2,


in LA136: R1 = R2 = RB3,


in LA137: R1 = R2 = RB4,


in LA138: R1 = R2 = RB5,


in LA139: R1 = R2 = RB6,


in LA140: R1 = R2 = RB7,


in LA141: R1 = R2 = RB8,


in LA142: R1 = R2 = RA2,


in LA143: R1 = R2 = RA22, and


in LA144: R1 = R2 = RA28;,


LA145 to LA155 represented by







embedded image







wherein in LA145: R1 = R2 = RB1,


in LA146: R1 = R2 = RB2,


in LA147: R1 = R2 = RB3,


in LA148: R1 = R2 = RB4,


in LA149: R1 = R2 = RB5,


in LA150: R1 = R2 = RB6,


in LA151: R1 = R2 = RB7,


in LA152: R1 = R2 = RB8,


in LA153: R1 = R2 = RA2,


in LA154: R1 = R2 = RA22, and


in LA155: R1 = R2 = RA28;,


LA158 to LA164 represented by







embedded image







wherein in LA156: R1 = RB2 and R2 = RB1,


in LA157: R1 = RB3 and R2 = RB1,


in LA158: R1 = RB5 and R2 = RB1,


in LA159: R1 = RA2 and R2 = RB1,


in LA160: R1 = RA28 and R2 = RB1,


in LA161: R1 = RB3 and R2 = RB2,


in LA162: R1 = RB5 and R2 = RB2,


in LA163: R1 = RA2 and R2 = RB2, and


in LA164: R1 = RA28 and R2 = RB2;


LA165 to LA175 represented by







embedded image







wherein in LA165: R1 and R2 = RB1,


in LA166: R1 = R2 = RB2,


in LA167: R1 = R2 = RB3,


in LA168: R1 = R2 = RB4,


in LA169: R1 = R2 = RB5,


in LA170: R1 = R2 = RB6,


in LA171: R1 = R2 = RB7,


in LA172: R1 = R2 = RB8,


in LA173: R1 = R2 = RA2,


in LA174: R1 = R2 = RA22, and


in LA175: R1 = R2 = RA28;,


L178 to LA186 represented by







embedded image







wherein in LA176: R1 = R2 = RB1,


in LA177: R1 = R2 = RB2,


in LA178: R1 = R2 = RB3,


in LA179: R1 = R2 = RB4,


in LA180: R1 = R2 = RB5,


in LA181: R1 = R2 = RB6,


in LA182: R1 = R2 = RB7,


in LA183: R1 = R2 = RB8,


in LA184: R1 = R2 = RA2,


in LA185: R1 = R2 = RA22, and


in LA186: R1 = R2 = RA28;,


LA187 to LA195 represented by







embedded image







wherein in LA187: R1 = RB2 and R2 = RB1,


in LA188: R1 = RB3 and R2 = RB1,


in LA189: R1 = RB5 and R2 = RB1,


in LA190: R1 = RA2 and R2 = RB1,


in LA191: R1 = RA28 and R2 = RB1,


in LA192: R1 = RB3 and R2 = RB2,


in LA193: R1 = RB5 and R2 = RB2,


in LA194: R1 = RA2 and R2 = RB2, and


in LA195: R1 = RA28 and R2 = RB2;,


LA196 to LA296 represented by







embedded image







wherein in LA196: R1 = R2 = RB1,


in LA197: R1 = R2 = RB2,


in LA198: R1 = R2 = RB3,


in LA199: R1 = R2 = RB4,


in LA200: R1 = R2 = RB5,


in LA201: R1 = R2 = RB6,


in LA202: R1 = R2 = RB7,


in LA203: R1 = R2 = RB8,


in LA204: R1 = R2 = RA2,


in LA205: R1 = R2 = RA22, and


in LA206: R1 = R2 = RA28;,


LA207 to LA217 represented by







embedded image







wherein in LA207: R1 = R2 = RB1,


in LA208: R1 = R2 = RB2,


in LA209: R1 = R2 = RB3,


in LA210: R1 = R2 = RB4,


in LA211: R1 = R2 = RB5,


in LA212: R1 = R2 = RB6,


in LA213: R1 = R2 = RB7,


in LA214: R1 = R2 = RB8,


in LA215: R1 = R2 = RA2,


in LA216: R1 = R2 = RA22, and


in LA217: R1 = R2 = RA28;,


LA218 to LA228 represented by







embedded image







wherein in LA218: R1 = RB2 and R2 = RB1;


in LA219: R1 = RB3 and R2 = RB1,


in LA220: R1 = RB5 and R2 = RB1,


in LA221: R1 = RA2 and R2 = RB1,


in LA222: R1 = RA28 and R2 = RB1,


in LA223: R1 = RB3 and R2 = RB2,


in LA224: R1 = RB5 and R2 = RB2,


in LA225: R1 = RA2 and R2 = RB2, and


in LA226: R1 = RA28 and R2 = RB2;,


LA227 to LA237 represented by







embedded image







wherein in LA227: R1 = R2 = RB1,


in LA228: R1 = R2 = RB2,


in LA229: R1 = R2 = RB3,


in LA230: R1 = R2 = RB4,


in LA231: R1 = R2 = RB5,


in LA232: R1 = R2 = RB6,


in LA233: R1 = R2 = RB7,


in LA234: R1 = R2 = RB8,


in LA235: R1 = R2 = RA2,


in LA236: R1 = R2 = RA22, and


in LA237: R1 = R2 = RA28;,


LA238 to LA248 represented by







embedded image







wherein in LA238: R1 = R2 = RB1,


in LA239: R1 = R2 = RB2,


in LA240: R1 = R2 = RB3,


in LA241: R1 = R2 = RB4,


in LA242: R1 = R2 = RB5,


in LA243: R1 = R2 = RB6,


in LA244: R1 = R2 = RB7,


in LA245: R1 = R2 = RB8,


in LA246: R1 = R2 = RA2,


in LA247: R1 = R2 = RA22, and


in LA248: R1 = R2 = RA28;,


LA249 to LA257 represented by







embedded image







wherein in L249: R1 = RB2 and R2 = RB1,


in LA250: R1 = RB3 and R2 = RB1,


in LA251: R1 = RB5 and R2 = RB1,


in LA252: R1 = RA2 and R2 = RB1,


in LA253: R1 = RA28 and R2 = RB1,


in LA254: R1 = RB3 and R2 = RB2,


in LA255: R1 = RB5 and R2 = RB2,


in LA256: R1 = RA2 and R2 = RB2, and


in LA257: R1 = RA28 and R2 = RB2;, and


LA258 to LA268 represented by







embedded image







wherein in L258: R1 = R2 = RB1,


in LA259: R1 = R2 = RB2,


in LA260: R1 = R2 = RB3,


in LA261: R1 = R2 = RB4,


in LA262: R1 = R2 = RB5,


in LA263: R1 = R2 = RB6,


in LA264: R1 = R2 = RB7,


in LA265: R1 = R2 = RB8,


in LA266: R1 = R2 = RA2,


in LA267: R1 = R2 = RA22, and


in LA268: R1 = R2 = RA28;,










wherein RB1 to RB8 have the following structures:




embedded image


and RA2, RA22, and RA28 have the structures as defined above.


According to some embodiments of the heteroleptic compound having the formula Ir(LA)n(LB)3−n, the ligand LB is selected from the group consisting of:




embedded image


embedded image


wherein each X1 to X3 are independently selected from the group consisting of carbon and nitrogen;

    • wherein X is selected from the group consisting of BR′, NR′, PR′, O, S, Se, C═O, S═O, SO2, CR′R″, SiR′R″, and GeR′R″;
    • wherein R′ and R″ are optionally fused or joined to form a ring;
    • wherein each Ra, Rb, Rc, and Rd may represent from mono substitution to the possible maximum number of substitution, or no substitution;
    • wherein R′, R″, Ra, Rb, Rc, and Rd are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and
    • wherein any two adjacent substitutents Ra, Rb, Rc, and Rd are optionally fused or joined to form a ring or form a multidentate ligand.


According to some embodiments of the heteroleptic compound having the formula Ir(LA)n(LB)3−n, the ligand LB is selected from the group consisting of:




embedded image


embedded image


embedded image


According to some embodiments of the heteroleptic compound having the formula Ir(LA)n(LB)3−n, the ligand LB is selected from the group consisting of:




embedded image




    • wherein, Ra and Rb are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and

    • wherein Ra and Rb are optionally fused or joined to form a ring or form a multidentate ligand.





According to some embodiments of the heteroleptic compound having the formula Ir(LA)n(LB)3−n, the ligand LB is selected from the group consisting of:




embedded image


embedded image


wherein, Ra and Rb are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and

    • wherein Ra and Rb are optionally fused or joined to form a ring or form a multidentate ligand.


According to some embodiments of the heteroleptic compound having the formula Ir(LA)n(LB)3−n, the ligand LB is selected from the group consisting of:




embedded image


embedded image


wherein, Ra, Rb, and Rc are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and

    • wherein any two of Ra, Rb, and Rc are optionally fused or joined to form a ring or form a multidentate ligand.


According to some embodiments of the heteroleptic compound having the formula Ir(LA)n(LB)3−n, the ligand LB is selected from the group consisting of LC1 through LC856 each of which has the structure of:




embedded image


wherein RC1, RC2, RC3, and RC4 are defined as follows:
















Lc
RC1
RC2
RC3
RC4



















1.
H
H
H
H


2.
CH3
H
H
H


3.
H
CH3
H
H


4.
H
H
CH3
H


5.
H
H
H
CH3


6.
CH3
H
CH3
H


7.
CH3
H
H
CH3


8.
H
CH3
CH3
H


9.
H
CH3
H
CH3


10.
H
H
CH3
CH3


11.
CH3
CH3
CH3
H


12.
CH3
CH3
H
CH3


13.
CH3
H
CH3
CH3


14.
H
CH3
CH3
CH3


15.
CH3
CH3
CH3
CH3


16.
CH2CH3
H
H
H


17.
CH2CH3
CH3
H
CH3


18.
CH2CH3
H
CH3
H


19.
CH2CH3
H
H
CH3


20.
CH2CH3
CH3
CH3
H


21.
CH2CH3
CH3
H
CH3


22.
CH2CH3
H
CH3
CH3


23.
CH2CH3
CH3
CH3
CH3


24.
H
CH2CH3
H
H


25.
CH3
CH2CH3
H
CH3


26.
H
CH2CH3
CH3
H


27.
H
CH2CH3
H
CH3


28.
CH3
CH2CH3
CH3
H


29.
CH3
CH2CH3
H
CH3


30.
H
CH2CH3
CH3
CH3


31.
CH3
CH2CH3
CH3
CH3


32.
H
H
CH2CH3
H


33.
CH3
H
CH2CH3
H


34.
H
CH3
CH2CH3
H


35.
H
H
CH2CH3
CH3


36.
CH3
CH3
CH2CH3
H


37.
CH3
H
CH2CH3
CH3


38.
H
CH3
CH2CH3
CH3


39.
CH3
CH3
CH2CH3
CH3


40.
CH(CH3)2
H
H
H


41.
CH(CH3)2
CH3
H
CH3


42.
CH(CH3)2
H
CH3
H


43.
CH(CH3)2
H
H
CH3


44.
CH(CH3)2
CH3
CH3
H


45.
CH(CH3)2
CH3
H
CH3


46.
CH(CH3)2
H
CH3
CH3


47.
CH(CH3)2
CH3
CH3
CH3


48.
H
CH(CH3)2
H
H


49.
CH3
CH(CH3)2
H
CH3


50.
H
CH(CH3)2
CH3
H


51.
H
CH(CH3)2
H
CH3


52.
CH3
CH(CH3)2
CH3
H


53.
CH3
CH(CH3)2
H
CH3


54.
H
CH(CH3)2
CH3
CH3


55.
CH3
CH(CH3)2
CH3
CH3


56.
H
H
CH(CH3)2
H


57.
CH3
H
CH(CH3)2
H


58.
H
CH3
CH(CH3)2
H


59.
H
H
CH(CH3)2
CH3


60.
CH3
CH3
CH(CH3)2
H


61.
CH3
H
CH(CH3)2
CH3


62.
H
CH3
CH(CH3)2
CH3


63.
CH3
CH3
CH(CH3)2
CH3


64.
CH2CH(CH3)2
H
H
H


65.
CH2CH(CH3)2
CH3
H
CH3


66.
CH2CH(CH3)2
H
CH3
H


67.
CH2CH(CH3)2
H
H
CH3


68.
CH2CH(CH3)2
CH3
CH3
H


69.
CH2CH(CH3)2
CH3
H
CH3


70.
CH2CH(CH3)2
H
CH3
CH3


71.
CH2CH(CH3)2
CH3
CH3
CH3


72.
H
CH2CH(CH3)2
H
H


73.
CH3
CH2CH(CH3)2
H
CH3


74.
H
CH2CH(CH3)2
CH3
H


75.
H
CH2CH(CH3)2
H
CH3


76.
CH3
CH2CH(CH3)2
CH3
H


77.
CH3
CH2CH(CH3)2
H
CH3


78.
H
CH2CH(CH3)2
CH3
CH3


79.
CH3
CH2CH(CH3)2
CH3
CH3


80.
H
H
CH2CH(CH3)2
H


81.
CH3
H
CH2CH(CH3)2
H


82.
H
CH3
CH2CH(CH3)2
H


83.
H
H
CH2CH(CH3)2
CH3


84.
CH3
CH3
CH2CH(CH3)2
H


85.
CH3
H
CH2CH(CH3)2
CH3


86.
H
CH3
CH2CH(CH3)2
CH3


87.
CH3
CH3
CH2CH(CH3)2
CH3


88.
C(CH3)3
H
H
H


89.
C(CH3)3
CH3
H
CH3


90.
C(CH3)3
H
CH3
H


91.
C(CH3)3
H
H
CH3


92.
C(CH3)3
CH3
CH3
H


93.
C(CH3)3
CH3
H
CH3


94.
C(CH3)3
H
CH3
CH3


95.
C(CH3)3
CH3
CH3
CH3


96.
H
C(CH3)3
H
H


97.
CH3
C(CH3)3
H
CH3


98.
H
C(CH3)3
CH3
H


99.
H
C(CH3)3
H
CH3


100.
CH3
C(CH3)3
CH3
H


101.
CH3
C(CH3)3
H
CH3


102.
H
C(CH3)3
CH3
CH3


103.
CH3
C(CH3)3
CH3
CH3


104.
H
H
C(CH3)3
H


105.
CH3
H
C(CH3)3
H


106.
H
CH3
C(CH3)3
H


107.
H
H
C(CH3)3
CH3


108.
CH3
CH3
C(CH3)3
H


109.
CH3
H
C(CH3)3
CH3


110.
H
CH3
C(CH3)3
CH3


111.
CH3
CH3
C(CH3)3
CH3


112.
CH2C(CH3)3
H
H
H


113.
CH2C(CH3)3
CH3
H
CH3


114.
CH2C(CH3)3
H
CH3
H


115.
CH2C(CH3)3
H
H
CH3


116.
CH2C(CH3)3
CH3
CH3
H


117.
CH2C(CH3)3
CH3
H
CH3


118.
CH2C(CH3)3
H
CH3
CH3


119.
CH2C(CH3)3
CH3
CH3
CH3


120.
H
CH2C(CH3)3
H
H


121.
CH3
CH2C(CH3)3
H
CH3


122.
H
CH2C(CH3)3
CH3
H


123.
H
CH2C(CH3)3
H
CH3


124.
CH3
CH2C(CH3)3
CH3
H


125.
CH3
CH2C(CH3)3
H
CH3


126.
H
CH2C(CH3)3
CH3
CH3


127.
CH3
CH2C(CH3)3
CH3
CH3


128.
H
H
CH2C(CH3)3
H


129.
CH3
H
CH2C(CH3)3
H


130.
H
CH3
CH2C(CH3)3
H


131.
H
H
CH2C(CH3)3
CH3


132.
CH3
CH3
CH2C(CH3)3
H


133.
CH3
H
CH2C(CH3)3
CH3


134.
H
CH3
CH2C(CH3)3
CH3


135.
CH3
CH3
CH2C(CH3)3
CH3


136.
CH2C(CH3)2CF3
H
H
H


137.
CH2C(CH3)2CF3
CH3
H
CH3


138.
CH2C(CH3)2CF3
H
CH3
H


139.
CH2C(CH3)2CF3
H
H
CH3


140.
CH2C(CH3)2CF3
CH3
CH3
H


141.
CH2C(CH3)2CF3
CH3
H
CH3


142.
CH2C(CH3)2CF3
H
CH3
CH3


143.
CH2C(CH3)2CF3
CH3
CH3
CH3


144.
H
CH2C(CH3)2CF3
H
H


145.
CH3
CH2C(CH3)2CF3
H
CH3


146.
H
CH2C(CH3)2CF3
CH3
H


147.
H
CH2C(CH3)2CF3
H
CH3


148.
CH3
CH2C(CH3)2CF3
CH3
H


149.
CH3
CH2C(CH3)2CF3
H
CH3


150.
H
CH2C(CH3)2CF3
CH3
CH3


151.
CH3
CH2C(CH3)2CF3
CH3
CH3


152.
H
H
CH2C(CH3)2CF3
H


153.
CH3
H
CH2C(CH3)2CF3
H


154.
H
CH3
CH2C(CH3)2CF3
H


155.
H
H
CH2C(CH3)2CF3
CH3


156.
CH3
CH3
CH2C(CH3)2CF3
H


157.
CH3
H
CH2C(CH3)2CF3
CH3


158.
H
CH3
CH2C(CH3)2CF3
CH3


159.
CH3
CH3
CH2C(CH3)2CF3
CH3


160.
CH2CH2CF3
H
H
H


161.
CH2CH2CF3
CH3
H
CH3


162.
CH2CH2CF3
H
CH3
H


163.
CH2CH2CF3
H
H
CH3


164.
CH2CH2CF3
CH3
CH3
H


165.
CH2CH2CF3
CH3
H
CH3


166.
CH2CH2CF3
H
CH3
CH3


167.
CH2CH2CF3
CH3
CH3
CH3


168.
H
CH2CH2CF3
H
H


169.
CH3
CH2CH2CF3
H
CH3


170.
H
CH2CH2CF3
CH3
H


171.
H
CH2CH2CF3
H
CH3


172.
CH3
CH2CH2CF3
CH3
H


173.
CH3
CH2CH2CF3
H
CH3


174.
H
CH2CH2CF3
CH3
CH3


175.
CH3
CH2CH2CF3
CH3
CH3


176.
H
H
CH2CH2CF3
H


177.
CH3
H
CH2CH2CF3
H


178.
H
CH3
CH2CH2CF3
H


179.
H
H
CH2CH2CF3
CH3


180.
CH3
CH3
CH2CH2CF3
H


181.
CH3
H
CH2CH2CF3
CH3


182.
H
CH3
CH2CH2CF3
CH3


183.
CH3
CH3
CH2CH2CF3
CH3





184.


embedded image


H
H
H





185.


embedded image


CH3
H
CH3





186.


embedded image


H
CH3
H





187.


embedded image


H
H
CH3





188.


embedded image


CH3
CH3
H





189.


embedded image


CH3
H
CH3





190.


embedded image


H
CH3
CH3





191.


embedded image


CH3
CH3
CH3





192.
H


embedded image


H
H





193.
CH3


embedded image


H
CH3





194.
H


embedded image


CH3
H





195.
H


embedded image


H
CH3





196.
CH3


embedded image


CH3
H





197.
CH3


embedded image


H
CH3





198.
H


embedded image


CH3
CH3





199.
CH3


embedded image


CH3
CH3





200.
H
H


embedded image


H





201.
CH3
H


embedded image


H





202.
H
CH3


embedded image


H





203.
H
H


embedded image


CH3





204.
CH3
CH3


embedded image


H





205.
CH3
H


embedded image


CH3





206.
H
CH3


embedded image


CH3





207.
CH3
CH3


embedded image


CH3





208.


embedded image


H
H
H





209.


embedded image


CH3
H
CH3





210.


embedded image


H
CH3
H





211.


embedded image


H
H
CH3





212.


embedded image


CH3
CH3
H





213.


embedded image


CH3
H
CH3





214.


embedded image


H
CH3
CH3





215.


embedded image


CH3
CH3
CH3





216.
H


embedded image


H
H





217.
CH3


embedded image


H
CH3





218.
H


embedded image


CH3
H





219.
H


embedded image


H
CH3





220.
CH3


embedded image


CH3
H





221.
CH3


embedded image


H
CH3





222.
H


embedded image


CH3
CH3





223.
CH3


embedded image


CH3
CH3





224.
H
H


embedded image


H





225.
CH3
H


embedded image


H





226.
H
CH3


embedded image


H





227.
H
H


embedded image


CH3





228.
CH3
CH3


embedded image


H





229.
CH3
H


embedded image


CH3





230.
H
CH3


embedded image


CH3





231.
CH3
CH3


embedded image


CH3





232.


embedded image


H
H
H





233.


embedded image


CH3
H
CH3





234.


embedded image


H
CH3
H





235.


embedded image


H
H
CH3





236.


embedded image


CH3
CH3
H





237.


embedded image


CH3
H
CH3





238.


embedded image


H
CH3
CH3





239.


embedded image


CH3
CH3
CH3





240.
H


embedded image


H
H





241.
CH3


embedded image


H
CH3





242.
H


embedded image


CH3
H





243.
H


embedded image


H
CH3





244.
CH3


embedded image


CH3
H





245.
CH3


embedded image


H
CH3





246.
H


embedded image


CH3
CH3





247.
CH3


embedded image


CH3
CH3





248.
H
H


embedded image


H





249.
CH3
H


embedded image


H





250.
H
CH3


embedded image


H





251.
H
H


embedded image


CH3





252.
CH3
CH3


embedded image


H





253.
CH3
H


embedded image


CH3





254.
H
CH3


embedded image


CH3





255.
CH3
CH3


embedded image


CH3





256.


embedded image


H
H
H





257.


embedded image


CH3
H
CH3





258.


embedded image


H
CH3
H





259.


embedded image


H
H
CH3





260.


embedded image


CH3
CH3
H





261.


embedded image


CH3
H
CH3





262.


embedded image


H
CH3
CH3





263.


embedded image


CH3
CH3
CH3





264.
H


embedded image


H
H





265.
CH3


embedded image


H
CH3





266.
H


embedded image


CH3
H





267.
H


embedded image


H
CH3





268.
CH3


embedded image


CH3
H





269.
CH3


embedded image


H
CH3





270.
H


embedded image


CH3
CH3





271.
CH3


embedded image


CH3
CH3





272.
H
H


embedded image


H





273.
CH3
H


embedded image


H





274.
H
CH3


embedded image


H





275.
H
H


embedded image


CH3





276.
CH3
CH3


embedded image


H





277.
CH3
H


embedded image


CH3





278.
H
CH3


embedded image


CH3





279.
CH3
CH3


embedded image


CH3





280.


embedded image


H
H
H





281.


embedded image


CH3
H
CH3





282.


embedded image


H
CH3
H





283.


embedded image


H
H
CH3





284.


embedded image


CH3
CH3
H





285.


embedded image


CH3
H
CH3





286.


embedded image


H
CH3
CH3





287.


embedded image


CH3
CH3
CH3





288.
H


embedded image


H
H





289.
CH3


embedded image


H
CH3





290.
H


embedded image


CH3
H





291.
H


embedded image


H
CH3





292.
CH3


embedded image


CH3
H





293.
CH3


embedded image


H
CH3





294.
H


embedded image


CH3
CH3





295.
CH3


embedded image


CH3
CH3





296.
H
H


embedded image


H





297.
CH3
H


embedded image


H





298.
H
CH3


embedded image


H





299.
H
H


embedded image


CH3





300.
CH3
CH3


embedded image


H





301.
CH3
H


embedded image


CH3





302.
H
CH3


embedded image


CH3





303.
CH3
CH3


embedded image


CH3





304.


embedded image


H
H
H





305.


embedded image


CH3
H
CH3





306.


embedded image


H
CH3
H





307.


embedded image


H
H
CH3





308.


embedded image


CH3
CH3
H





309.


embedded image


CH3
H
CH3





310.


embedded image


H
CH3
CH3





311.


embedded image


CH3
CH3
CH3





312.
H


embedded image


H
H





313.
CH3


embedded image


H
CH3





314.
H


embedded image


CH3
H





315.
H


embedded image


H
CH3





316.
CH3


embedded image


CH3
H





317.
CH3


embedded image


H
CH3





318.
H


embedded image


CH3
CH3





319.
CH3


embedded image


CH3
CH3





320.
H
H


embedded image


H





321.
CH3
H


embedded image


H





322.
H
CH3


embedded image


H





323.
H
H


embedded image


CH3





324.
CH3
CH3


embedded image


H





325.
CH3
H


embedded image


CH3





326.
H
CH3


embedded image


CH3





327.
CH3
CH3


embedded image


CH3





328.
CH(CH3)2
H
CH2CH3
H


329.
CH(CH3)2
H
CH(CH3)2
H


330.
CH(CH3)2
H
CH2CH(CH3)2
H


331.
CH(CH3)2
H
C(CH3)3
H


332.
CH(CH3)2
H
CH2C(CH3)3
H


333.
CH(CH3)2
H
CH2CH2CF3
H


334.
CH(CH3)2
H
CH2C(CH3)2CF3
H





335.
CH(CH3)2
H


embedded image


H





336.
CH(CH3)2
H


embedded image


H





337.
CH(CH3)2
H


embedded image


H





338.
CH(CH3)2
H


embedded image


H





339.
CH(CH3)2
H


embedded image


H





340.
CH(CH3)2
H


embedded image


H





341.
C(CH3)3
H
CH2CH3
H


342.
C(CH3)3
H
CH(CH3)2
H


343.
C(CH3)3
H
CH2CH(CH3)2
H


344.
C(CH3)3
H
C(CH3)3
H


345.
C(CH3)3
H
CH2C(CH3)3
H


346.
C(CH3)3
H
CH2CH2CF3
H


347.
C(CH3)3
H
CH2C(CH3)2CF3
H





348.
C(CH3)3
H


embedded image


H





349.
C(CH3)3
H


embedded image


H





350.
C(CH3)3
H


embedded image


H





351.
C(CH3)3
H


embedded image


H





352.
C(CH3)3
H


embedded image


H





353.
C(CH3)3
H


embedded image


H





354.
CH2C(CH3)3
H
CH2CH3
H


355.
CH2C(CH3)3
H
CH(CH3)2
H


356.
CH2C(CH3)3
H
CH2CH(CH3)2
H


357.
CH2C(CH3)3
H
C(CH3)3
H


358.
CH2C(CH3)3
H
CH2C(CH3)3
H


359.
CH2C(CH3)3
H
CH2CH2CF3
H


360.
CH2C(CH3)3
H
CH2C(CH3)2CF3
H





361.
CH2C(CH3)3
H


embedded image


H





362.
CH2C(CH3)3
H


embedded image


H





363.
CH2C(CH3)3
H


embedded image


H





364.
CH2C(CH3)3
H


embedded image


H





365.
CH2C(CH3)3
H


embedded image


H





366.
CH2C(CH3)3
H


embedded image


H





367.


embedded image


H
CH2CH3
H





368.


embedded image


H
CH(CH3)2
H





369.


embedded image


H
CH2CH(CH3)2
H





370.


embedded image


H
C(CH3)3
H





371.


embedded image


H
CH2C(CH3)3
H





372.


embedded image


H
CH2CH2CF3
H





373.


embedded image


H
CH2C(CH3)2CF3
H





374.


embedded image


H


embedded image


H





375.


embedded image


H


embedded image


H





376.


embedded image


H


embedded image


H





377.


embedded image


H


embedded image


H





378.


embedded image


H


embedded image


H





379.


embedded image


H


embedded image


H





380.


embedded image


H
CH2CH3
H





381.


embedded image


H
CH(CH3)2
H





382.


embedded image


H
CH2CH(CH3)2
H





383.


embedded image


H
C(CH3)3
H





384.


embedded image


H
CH2C(CH3)3
H





385.


embedded image


H
CH2CH2CF3
H





386.


embedded image


H
CH2C(CH3)2CF3
H





387.


embedded image


H


embedded image


H





388.


embedded image


H


embedded image


H





389.


embedded image


H


embedded image


H





390.


embedded image


H


embedded image


H





391.


embedded image


H


embedded image


H





392.


embedded image


H


embedded image


H





393.


embedded image


H
CH2CH(CH3)2
H





394.


embedded image


H
C(CH3)3
H





395.


embedded image


H
CH2C(CH3)3
H





396.


embedded image


H
CH2CH2CF3
H





397.


embedded image


H
CH2C(CH3)2CF3
H





398.


embedded image


H


embedded image


H





399.


embedded image


H


embedded image


H





400.


embedded image


H


embedded image


H





401.


embedded image


H


embedded image


H





402.


embedded image


H


embedded image


H





403.


embedded image


H


embedded image


H





404.


embedded image


H
CH2CH(CH3)2
H





405.


embedded image


H
C(CH3)3
H





406.


embedded image


H
CH2C(CH3)3
H





407.


embedded image


H
CH2CH2CF3
H





408.


embedded image


H
CH2C(CH3)2CF3
H





409.


embedded image


H


embedded image


H





410.


embedded image


H


embedded image


H





411.


embedded image


H


embedded image


H





412.


embedded image


H


embedded image


H





413.


embedded image


H


embedded image


H





414.


embedded image


H


embedded image


H





415.


embedded image


H
CH2CH(CH3)2
H





416.


embedded image


H
C(CH3)3
H





417.


embedded image


H
CH2C(CH3)3
H





418.


embedded image


H
CH2CH2CF3
H





419.


embedded image


H
CH2C(CH3)2CF3
H





420.


embedded image


H


embedded image


H





421.


embedded image


H


embedded image


H





422.


embedded image


H


embedded image


H





423.


embedded image


H


embedded image


H





424.


embedded image


H


embedded image


H





425.


embedded image


H


embedded image


H





426.
H
H
H
H


427.
CD3
H
H
H


428.
H
CD3
H
H


429.
H
H
CD3
H


430.
H
H
H
CD3


431.
CD3
H
CD3
H


432.
CD3
H
H
CD3


433.
H
CD3
CH3
H


434.
H
CD3
H
CD3


435.
H
H
CD3
CD3


436.
CD3
CD3
CD3
H


437.
CD3
CD3
H
CD3


438.
CD3
H
CD3
CD3


439.
H
CD3
CD3
CD3


440.
CD3
CD3
CD3
CD3


441.
CD2CH3
H
H
H


442.
CD2CH3
CD3
H
CD3


443.
CD2CH3
H
CD3
H


444.
CD2CH3
H
H
CD3


445.
CD2CH3
CD3
CD3
H


446.
CD2CH3
CD3
H
CD3


447.
CD2CH3
H
CD3
CD3


448.
CD2CH3
CD3
CD3
CD3


449.
H
CD2CH3
H
H


450.
CH3
CD2CH3
H
CD3


451.
H
CD2CH3
CD3
H


452.
H
CD2CH3
H
CD3


453.
CD3
CD2CH3
CD3
H


454.
CD3
CD2CH3
H
CD3


455.
H
CD2CH3
CD3
CD3


456.
CD3
CD2CH3
CD3
CD3


457.
H
H
CD2CH3
H


458.
CD3
H
CD2CH3
H


459.
H
CD3
CD2CH3
H


460.
H
H
CD2CH3
CD3


461.
CD3
CD3
CD2CH3
H


462.
CD3
H
CD2CH3
CD3


463.
H
CD3
CD2CH3
CD3


464.
CD3
CD3
CD2CH3
CD3


465.
CD(CH3)2
H
H
H


466.
CD(CH3)2
CD3
H
CD3


467.
CD(CH3)2
H
CD3
H


468.
CD(CH3)2
H
H
CD3


469.
CD(CH3)2
CD3
CD3
H


470.
CD(CH3)2
CD3
H
CD3


471.
CD(CH3)2
H
CD3
CD3


472.
CD(CH3)2
CD3
CD3
CD3


473.
H
CD(CH3)2
H
H


474.
CD3
CD(CH3)2
H
CD3


475.
H
CD(CH3)2
CD3
H


476.
H
CD(CH3)2
H
CD3


477.
CD3
CD(CH3)2
CD3
CD3


478.
CD3
CD(CH3)2
H
CD3


479.
H
CD(CH3)2
CD3
CD3


480.
CD3
CD(CH3)2
CD3
CD3


481.
H
H
CD(CH3)2
H


482.
CD3
H
CD(CH3)2
H


483.
H
CD3
CD(CH3)2
H


484.
H
H
CD(CH3)2
CD3


485.
CD3
CD3
CD(CH3)2
H


486.
CD3
H
CD(CH3)2
CD3


487.
H
CD3
CD(CH3)2
CD3


488.
CD3
CD3
CD(CH3)2
CD3


489.
CD(CD3)2
H
H
H


490.
CD(CD3)2
CD3
H
CD3


491.
CD(CD3)2
H
CD3
H


492.
CD(CD3)2
H
H
CD3


493.
CD(CD3)2
CD3
CD3
H


494.
CD(CD3)2
CD3
H
CD3


495.
CD(CD3)2
H
CD3
CD3


496.
CD(CD3)2
CD3
CD3
CD3


497.
H
CD(CD3)2
H
H


498.
CH3
CD(CD3)2
H
CD3


499.
H
CD(CD3)2
CD3
H


500.
H
CD(CD3)2
H
CD3


501.
CD3
CD(CD3)2
CD3
H


502.
CD3
CD(CD3)2
H
CD3


503.
H
CD(CD3)2
CD3
CD3


504.
CD3
CD(CD3)2
CD3
CD3


505.
H
H
CD(CD3)2
H


506.
CD3
H
CD(CD3)2
H


507.
H
CD3
CD(CD3)2
H


508.
H
H
CD(CD3)2
CD3


509.
CD3
CD3
CD(CD3)2
H


510.
CD3
H
CD(CD3)2
CD3


511.
H
CD3
CD(CD3)2
CD3


512.
CD3
CD3
CD(CD3)2
CD3


513.
CD2CH(CH3)2
H
H
H


514.
CD2CH(CH3)2
CD3
H
CD3


515.
CD2CH(CH3)2
H
CD3
H


516.
CD2CH(CH3)2
H
H
CD3


517.
CD2CH(CH3)2
CD3
CD3
H


518.
CD2CH(CH3)2
CD3
H
CD3


519.
CD2CH(CH3)2
H
CD3
CD3


520.
CD2CH(CH3)2
CD3
CD3
CD3


521.
H
CD2CH(CH3)2
H
H


522.
CD3
CD2CH(CH3)2
H
CD3


523.
H
CD2CH(CH3)2
CD3
H


524.
H
CD2CH(CH3)2
H
CD3


525.
CD3
CD2CH(CH3)2
CD3
H


526.
CD3
CD2CH(CH3)2
H
CD3


527.
H
CD2CH(CH3)2
CD3
CD3


528.
CD3
CD2CH(CH3)2
CD3
CD3


529.
H
H
CD2CH(CH3)2
H


530.
CD3
H
CD2CH(CH3)2
H


531.
H
CD3
CD2CH(CH3)2
H


532.
H
H
CD2CH(CH3)2
CD3


533.
CD3
CD3
CD2CH(CH3)2
H


534.
CD3
H
CD2CH(CH3)2
CD3


535.
H
CD3
CD2CH(CH3)2
CD3


536.
CD3
CD3
CD2CH(CH3)2
CD3


537.
CD2C(CH3)3
H
H
H


538.
CD2C(CH3)3
CD3
H
CD3


539.
CD2C(CH3)3
H
CD3
H


540.
CD2C(CH3)3
H
H
CD3


541.
CD2C(CH3)3
CD3
CD3
H


542.
CD2C(CH3)3
CD3
H
CD3


543.
CD2C(CH3)3
H
CD3
CD3


544.
CD2C(CH3)3
CH3
CD3
CD3


545.
H
CD2C(CH3)3
H
H


546.
CD3
CD2C(CH3)3
H
CD3


547.
H
CD2C(CH3)3
CD3
H


548.
H
CD2C(CH3)3
H
CD3


549.
CD3
CD2C(CH3)3
CD3
H


550.
CD3
CD2C(CH3)3
H
CD3


551.
H
CD2C(CH3)3
CD3
CD3


552.
CD3
CD2C(CH3)3
CD3
CD3


553.
H
H
CD2C(CH3)3
H


554.
CD3
H
CD2C(CH3)3
H


555.
H
CD3
CD2C(CH3)3
H


556.
H
H
CD2C(CH3)3
CD3


557.
CD3
CD3
CD2C(CH3)3
H


558.
CD3
H
CD2C(CH3)3
CD3


559.
H
CD3
CD2C(CH3)3
CD3


560.
CD3
CD3
CD2C(CH3)3
CD3


561.
CD2C(CH3)2CF3
H
H
H


562.
CD2C(CH3)2CF3
CD3
H
CD3


563.
CD2C(CH3)2CF3
H
CD3
H


564.
CD2C(CH3)2CF3
H
H
CD3


565.
CD2C(CH3)2CF3
CD3
CD3
H


566.
CD2C(CH3)2CF3
CD3
H
CD3


567.
CD2C(CH3)2CF3
H
CD3
CD3


568.
CD2C(CH3)2CF3
CD3
CD3
CD3


569.
H
CD2C(CH3)2CF3
H
H


570.
CD3
CD2C(CH3)2CF3
H
CD3


571.
H
CD2C(CH3)2CF3
CD3
H


572.
H
CD2C(CH3)2CF3
H
CD3


573.
CD3
CD2C(CH3)2CF3
CD3
H


574.
CD3
CD2C(CH3)2CF3
H
CD3


575.
H
CD2C(CH3)2CF3
CD3
CD3


576.
CD3
CD2C(CH3)2CF3
CD3
CD3


577.
H
H
CD2C(CH3)2CF3
H


578.
CD3
H
CD2C(CH3)2CF3
H


579.
H
CD3
CD2C(CH3)2CF3
H


580.
H
H
CD2C(CH3)2CF3
CD3


581.
CD3
CD3
CD2C(CH3)2CF3
H


582.
CD3
H
CD2C(CH3)2CF3
CD3


583.
H
CD3
CD2C(CH3)2CF3
CD3


584.
CD3
CD3
CD2C(CH3)2CF3
CD3


585.
CD2CH2CF3
H
H
H


586.
CD2CH2CF3
CD3
H
CD3


587.
CD2CH2CF3
H
CD3
H


588.
CD2CH2CF3
H
H
CD3


589.
CD2CH2CF3
CD3
CD3
H


590.
CD2CH2CF3
CD3
H
CD3


591.
CD2CH2CF3
H
CD3
CD3


592.
CD2CH2CF3
CD3
CD3
CD3


593.
H
CD2CH2CF3
H
H


594.
CD3
CD2CH2CF3
H
CD3


595.
H
CD2CH2CF3
CD3
H


596.
H
CD2CH2CF3
H
CD3


597.
CD3
CD2CH2CF3
CD3
H


598.
CD3
CD2CH2CF3
H
CD3


599.
H
CD2CH2CF3
CD3
CD3


600.
CD3
CD2CH2CF3
CD3
CD3


601.
H
H
CD2CH2CF3
H


602.
CD3
H
CD2CH2CF3
H


603.
H
CD3
CD2CH2CF3
H


604.
H
H
CD2CH2CF3
CD3


605.
CD3
CD3
CD2CH2CF3
H


606.
CD3
H
CD2CH2CF3
CD3


607.
H
CD3
CD2CH2CF3
CD3


608.
CD3
CD3
CD2CH2CF3
CD3





609.


embedded image


H
H
H





610.


embedded image


CD3
H
CD3





611.


embedded image


H
CD3
H





612.


embedded image


H
H
CD3





613.


embedded image


CD3
CD3
H





614.


embedded image


CD3
H
CD3





615.


embedded image


H
CD3
CD3





616.


embedded image


CD3
CD3
CD3





617.
H


embedded image


H
H





618.
CD3


embedded image


H
CD3





619.
H


embedded image


CD3
H





620.
H


embedded image


H
CD3





621.
CD3


embedded image


CD3
H





622.
CD3


embedded image


H
CD3





623.
H


embedded image


CD3
CD3





624.
CD3


embedded image


CD3
CD3





625.
H
H


embedded image


H





626.
CD3
H


embedded image


H





627.
H
CD3


embedded image


H





628.
H
H


embedded image


CD3





629.
CD3
CD3


embedded image


H





630.
CD3
H


embedded image


CD3





631.
H
CD3


embedded image


CD3





632.
CD3
CD3


embedded image


CD3





633.


embedded image


H
H
H





634.


embedded image


CD3
H
CD3





635.


embedded image


H
CD3
H





636.


embedded image


H
H
CD3





637.


embedded image


CD3
CD3
H





638.


embedded image


CD3
H
CD3





639.


embedded image


H
CD3
CD3





640.


embedded image


CD3
CD3
CD3





641.
H


embedded image


H
H





642.
CH3


embedded image


H
CD3





643.
H


embedded image


CD3
H





644.
H


embedded image


H
CD3





645.
CD3


embedded image


CD3
H





646.
CD3


embedded image


H
CD3





647.
H


embedded image


CD3
CD3





648.
CH3


embedded image


CD3
CD3





649.
H
H


embedded image


H





650.
CD3
H


embedded image


H





651.
H
CD3


embedded image


H





652.
H
H


embedded image


CD3





653.
CD3
CD3


embedded image


H





654.
CD3
H


embedded image


CD3





655.
H
CD3


embedded image


CD3





656.
CD3
CD3


embedded image


CD3





657.


embedded image


H
H
H





658.


embedded image


CD3
H
CD3





659.


embedded image


H
CD3
H





660.


embedded image


H
H
CD3





661.


embedded image


CD3
CD3
H





662.


embedded image


CD3
H
CD3





663.


embedded image


H
CD3
CD3





664.


embedded image


CD3
CD3
CD3





665.
H


embedded image


H
H





666.
CD3


embedded image


H
CD3





667.
H


embedded image


CD3
H





668.
H


embedded image


H
CD3





669.
CD3


embedded image


CD3
H





670.
CD3


embedded image


H
CD3





671.
H


embedded image


CD3
CD3





672.
CD3


embedded image


CD3
CD3





673.
H
H


embedded image


H





674.
CD3
H


embedded image


H





675.
H
CD3


embedded image


H





676.
H
H


embedded image


CD3





677.
CD3
CD3


embedded image


H





678.
CD3
H


embedded image


CD3





679.
H
CD3


embedded image


CD3





680.
CD3
CD3


embedded image


CD3





681.


embedded image


H
H
H





682.


embedded image


CD3
H
CD3





683.


embedded image


H
CD3
H





684.


embedded image


H
H
CD3





685.


embedded image


CD3
CD3
H





686.


embedded image


CD3
H
CD3





687.


embedded image


H
CD3
CD3





688.


embedded image


CD3
CD3
CD3





689.
H


embedded image


H
H





690.
CD3


embedded image


H
CD3





691.
H


embedded image


CD3
H





692.
H


embedded image


H
CD3





693.
CD3


embedded image


CD3
H





694.
CD3


embedded image


H
CD3





695.
H


embedded image


CD3
CD3





696.
CD3


embedded image


CD3
CD3





697.
H
H


embedded image


H





698.
CD3
H


embedded image


H





699.
H
CD3


embedded image


H





700.
H
H


embedded image


CD3





701.
CD3
CD3


embedded image


H





702.
CD3
H


embedded image


CD3





703.
H
CD3


embedded image


CD3





704.
CD3
CD3


embedded image


CD3





705.


embedded image


H
H
H





706.


embedded image


CD3
H
CD3





707.


embedded image


H
CD3
H





708.


embedded image


H
H
CD3





709.


embedded image


CD3
CD3
H





710.


embedded image


CD3
H
CD3





711.


embedded image


H
CD3
CD3





712.


embedded image


CD3
CD3
CD3





713.
H


embedded image


H
H





714.
CD3


embedded image


H
CD3





715.
H


embedded image


CD3
H





716.
H


embedded image


H
CD3





717.
CD3


embedded image


CD3
H





718.
CD3


embedded image


H
CD3





719.
H


embedded image


CD3
CD3





720.
CD3


embedded image


CD3
CD3





721.
H
H


embedded image


H





722.
CD3
H


embedded image


H





723.
H
CD3


embedded image


H





724.
H
H


embedded image


CD3





725.
CD3
CD3


embedded image


H





726.
CD3
H


embedded image


CD3





727.
H
CD3


embedded image


CD3





728.
CD3
CD3


embedded image


CD3





729.


embedded image


H
H
H





730.


embedded image


CD3
H
CD3





731.


embedded image


H
CD3
H





732.


embedded image


H
H
CD3





733.


embedded image


CH3
CH3
H





734.


embedded image


CD3
H
CD3





735.


embedded image


H
CD3
CD3





736.


embedded image


CD3
CD3
CD3





737.
H


embedded image


H
H





738.
CD3


embedded image


H
CD3





739.
H


embedded image


CD3
H





740.
H


embedded image


H
CD3





741.
CD3


embedded image


CD3
H





742.
CD3


embedded image


H
CD3





743.
H


embedded image


CD3
CD3





744.
CD3


embedded image


CD3
CD3





745.
H
H


embedded image


H





746.
CD3
H


embedded image


H





747.
H
CD3


embedded image


H





748.
H
H


embedded image


CH3





749.
CD3
CD3


embedded image


H





750.
CD3
H


embedded image


CD3





751.
H
CD3


embedded image


CD3





752.
CD3
CD3


embedded image


CD3





753.
CD(CH3)2
H
CD2CH3
H


754.
CD(CH3)2
H
CD(CH3)2
H


755.
CD(CH3)2
H
CD2CH(CH3)2
H


756.
CD(CH3)2
H
C(CH3)3
H


757.
CD(CH3)2
H
CD2C(CH3)3
H


758.
CD(CH3)2
H
CD2CH2CF3
H


759.
CD(CH3)2
H
CD2C(CH3)2CF3
H





760.
CD(CH3)2
H


embedded image


H





761.
CD(CH3)2
H


embedded image


H





762.
CD(CH3)2
H


embedded image


H





763.
CD(CH3)2
H


embedded image


H





764.
CD(CH3)2
H


embedded image


H





765.
CD(CH3)2
H


embedded image


H





766.
C(CH3)3
H
CD2CH3
H


767.
C(CH3)3
H
CD(CH3)2
H


768.
C(CH3)3
H
CD2CH(CH3)2
H


769.
C(CH3)3
H
C(CH3)3
H


770.
C(CH3)3
H
CD2C(CH3)3
H


771.
C(CH3)3
H
CD2CH2CF3
H


772.
C(CH3)3
H
CD2C(CH3)2CF3
H





773.
C(CH3)3
H


embedded image


H





774.
C(CH3)3
H


embedded image


H





775.
C(CH3)3
H


embedded image


H





776.
C(CH3)3
H


embedded image


H





777.
C(CH3)3
H


embedded image


H





778.
C(CH3)3
H


embedded image


H





779.
CD2C(CH3)3
H
CD2CH3
H


780.
CD2C(CH3)3
H
CD(CH3)2
H


781.
CD2C(CH3)3
H
CD2CH(CH3)2
H


782.
CD2C(CH3)3
H
C(CH3)3
H


783.
CD2C(CH3)3
H
CD2C(CH3)3
H


784.
CD2C(CH3)3
H
CD2CH2CF3
H


785.
CD2C(CH3)3
H
CD2C(CH3)2CF3
H





786.
CD2C(CH3)3
H


embedded image


H





787.
CD2C(CH3)3
H


embedded image


H





788.
CD2C(CH3)3
H


embedded image


H





789.
CD2C(CH3)3
H


embedded image


H





790.
CD2C(CH3)3
H


embedded image


H





791.
CD2C(CH3)3
H


embedded image


H





792.


embedded image


H
CD2CH3
H





793.


embedded image


H
CD(CH3)2
H





794.


embedded image


H
CD2CH(CH3)2
H





795.


embedded image


H
C(CH3)3
H





796.


embedded image


H
CD2C(CH3)3
H





797.


embedded image


H
CD2CH2CF3
H





798.


embedded image


H
CD2C(CH3)2CF3
H





799.


embedded image


H


embedded image


H





800.


embedded image


H


embedded image


H





801.


embedded image


H


embedded image


H





802.


embedded image


H


embedded image


H





803.


embedded image


H


embedded image


H





804.


embedded image


H


embedded image


H





805.


embedded image


H
CD2CH3
H





806.


embedded image


H
CD(CH3)2
H





807.


embedded image


H
CD2CH(CH3)2
H





808.


embedded image


H
C(CH3)3
H





809.


embedded image


H
CD2C(CH3)3
H





810.


embedded image


H
CD2CH2CF3
H





811.


embedded image


H
CD2C(CH3)2CF3
H





812.


embedded image


H


embedded image


H





813.


embedded image


H


embedded image


H





814.


embedded image


H


embedded image


H





815.


embedded image


H


embedded image


H





816.


embedded image


H


embedded image


H





817.


embedded image


H


embedded image


H





818.


embedded image


H
CD2CH3
H





819.


embedded image


H
CD(CH3)2
H





820.


embedded image


H
CD2CH(CH3)2
H





821.


embedded image


H
C(CH3)3
H





822.


embedded image


H
CD2C(CH3)3
H





823.


embedded image


H
CD2CH2CF3
H





824.


embedded image


H
CD2C(CH3)2CF3
H





825.


embedded image


H


embedded image


H





826.


embedded image


H


embedded image


H





827.


embedded image


H


embedded image


H





828.


embedded image


H


embedded image


H





829.


embedded image


H


embedded image


H





830.


embedded image


H


embedded image


H





831.


embedded image


H
CD2CH3
H





832.


embedded image


H
CD(CH3)2
H





833.


embedded image


H
CD2CH(CH3)2
H





834.


embedded image


H
C(CH3)3
H





835.


embedded image


H
CD2C(CH3)3
H





836.


embedded image


H
CD2CH2CF3
H





837.


embedded image


H
CD2C(CH3)2CF3
H





838.


embedded image


H


embedded image


H





839.


embedded image


H


embedded image


H





840.


embedded image


H


embedded image


H





841.


embedded image


H


embedded image


H





842.


embedded image


H


embedded image


H





843.


embedded image


H


embedded image


H





844.


embedded image


H
CD2CH3
H





845.


embedded image


H
CD(CH3)2
H





846.


embedded image


H
CD2CH(CH3)2
H





847.


embedded image


H
C(CH3)3
H





848.


embedded image


H
CD2C(CH3)3
H





849.


embedded image


H
CD2CH2CF3
H





850.


embedded image


H
CD2C(CH3)2CF3
H





851.


embedded image


H


embedded image


H





852.


embedded image


H


embedded image


H





853.


embedded image


H


embedded image


H





854.


embedded image


H


embedded image


H





855.


embedded image


H


embedded image


H





856.


embedded image


H


embedded image


H









According to some embodiments of the heteroleptic compound having the formula Ir(LA)n(LB)3−n, the compound is selected from the group consisting of Compound A-1 through Compound A-4556 and Compound B-1 through Compound B-229,408;

    • wherein each Compound A-x has the formula Ir(LAi)2(LBj);
    • wherein x=268j+i−268, i is an integer from 1 to 268, and j is an integer from 1 to 17;
    • wherein each Compound B-y has the formula Ir(LAi)(LCk)2;
    • wherein y=268k+i−268, i is an integer from 1 to 268, and k is an integer from 1 to 856;
    • wherein LAi, LBj and LCk have the structures as defined above.


According to another aspect of the present disclosure, a first organic light emitting device incorporating the heteroleptic compound is disclosed. The organic light emitting device comprising: an anode; a cathode; and an organic layer, disposed between the anode and the cathode, comprising a heteroleptic compound having a formula Ir(LA)n(LB)3−n:


wherein the ligand LA is




embedded image




    • wherein the ligand LB is







embedded image




    • wherein LA is a different ligand from LB;

    • wherein n is 1 or 2;

    • wherein rings A, C, and D are each independently a 5-membered or 6-membered carbocyclic or heterocyclic ring;

    • wherein RA, RC, and RD each independently represent mono, di, tri, or tetra-substitution, or no substitution;

    • wherein RB represents mono, di, tri, or tetra-substitution;

    • wherein at least one RB has the following structure:







embedded image




    • wherein X1, X2, X3, X4, and X5 are each independently carbon or nitrogen;

    • wherein RA, RB, RC, RD, RX, RY, and RZ are each independently selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and any two adjacent substituents are optionally joined or fused into a ring;

    • wherein R1, and R2 are each independently selected from the group consisting of alkyl, cycloalkyl, partially fluorinated alkyl, partially fluorinated cycloalkyl, and their partially deuterated or fully deuterated analogs, and combinations thereof;

    • wherein in each of the R1, and R2, if a carbon having a fluorine atom attached thereto, then this carbon is separated by at least one carbon atom from the ring E; and

    • wherein in each of the R1, and R2, carbon attaching to ring E is a primary, secondary, tertiary, or a quaternary carbon.





In some embodiments, the first organic light emitting device is incorporated into a device selected from the group consisting of a consumer product, an electronic component module, an organic light-emitting device, and a lighting panel.


In some embodiments of the first organic light emitting device, the organic layer is an emissive layer and the compound is an emissive dopant or a non-emissive dopant.


In some embodiments of the first organic light emitting device, the organic layer further comprises a host, wherein the host comprises a triphenylene containing benzo-fused thiophene or benzo-fused furan;

    • wherein any substituent in the host is an unfused substituent independently selected from the group consisting of CnH2n+1, OCnH2n+1, OAr1, N(CnH2n+1)2, N(Ar1)(Ar2), CH═CH—CnH2n+1, C≡C—CnH2n+1, Ar1, Ar1—Ar2, and CnH2n—Ar1, or the host has no substitutions;
    • wherein n is from 1 to 10; and
    • wherein Ar1 and Ar2 are independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof.


In some embodiments of the first organic light emitting device, the host in the organic layer comprises at least one chemical group selected from the group consisting of carbazole, dibenzothiphene, dibenzofuran, dibenzoselenophene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene.


In some embodiments of the first organic light emitting device, the host in the organic layer is selected from the group consisting of:




embedded image


embedded image


embedded image


embedded image


and combinations thereof.


In some embodiments of the first organic light emitting device, the host in the organic layer comprises a metal complex.


The organic light emitting device disclosed herein can be incorporated into one or more of a consumer product, an electronic component module, an organic light-emitting device, and a lighting panel. The organic layer can be an emissive layer and the compound can be an emissive dopant in some embodiments, while the compound can be a non-emissive dopant in other embodiments.


The organic layer can also include a host. In some embodiments, two or more hosts are preferred. In some embodiments, the hosts used may be a) bipolar, b) electron transporting, c) hole transporting or d) wide band gap materials that play little role in charge transport. In some embodiments, the host can include a metal complex. The host can be a triphenylene containing benzo-fused thiophene or benzo-fused furan. Any substituent in the host can be an unfused substituent independently selected from the group consisting of CnH2n+1, OCnH2n+1, OAr1, N(Cn H2n+1)2, N(Ar1)(Ar2), CH═CH—CnH2n+1, C≡C—CnH2n+1, Ar1, Ar1—Ar2, and CnH2n—Ar1, or the host has no substitution. In the preceding substituents n can range from 1 to 10; and Ar1 and Ar2 can be independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof. The host can be an inorganic compound. For example a Zn containing inorganic material e.g. ZnS.


The host can be a compound comprising at least one chemical group selected from the group consisting of triphenylene, carbazole, dibenzothiphene, dibenzofuran, dibenzoselenophene, azatriphenylene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene. The host can include a metal complex.


The host can be, but is not limited to, a specific compound selected from the group consisting of:




embedded image


embedded image


embedded image


embedded image


embedded image


and combinations thereof. Additional information on possible hosts is provided below.


According to another aspect of the present disclosure, a formulation comprising a heteroleptic compound having the formula Ir(LA)n(LB)3−n defined above is disclosed. The formulation can include one or more components selected from the group consisting of a solvent, a host, a hole injection material, hole transport material, and an electron transport layer material, disclosed herein.


Combination with Other Materials

The materials described herein as useful for a particular layer in an organic light emitting device may be used in combination with a wide variety of other materials present in the device. For example, emissive dopants disclosed herein may be used in conjunction with a wide variety of hosts, transport layers, blocking layers, injection layers, electrodes and other layers that may be present. The materials described or referred to below are non-limiting examples of materials that may be useful in combination with the compounds disclosed herein, and one of skill in the art can readily consult the literature to identify other materials that may be useful in combination.


Conductivity Dopants:

A charge transport layer can be doped with conductivity dopants to substantially alter its density of charge carriers, which will in turn alter its conductivity. The conductivity is increased by generating charge carriers in the matrix material, and depending on the type of dopant, a change in the Fermi level of the semiconductor may also be achieved. Hole-transporting layer can be doped by p-type conductivity dopants and n-type conductivity dopants are used in the electron-transporting layer. Non-limiting examples of the conductivity dopants that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials:


EP01617493, EP01968131, EP2020694, EP2684932, US20050139810, US20070160905, US20090167167, US2010288362, WO06081780, WO2009003455, WO2009008277, WO2009011327, WO2014009310, US2007252140, US2015060804 and US2012146012.




embedded image


embedded image


HIL/HTL:

A hole injecting/transporting material to be used in the present invention is not particularly limited, and any compound may be used as long as the compound is typically used as a hole injecting/transporting material. Examples of the material include, but are not limited to: a phthalocyanine or porphyrin derivative; an aromatic amine derivative; an indolocarbazole derivative; a polymer containing fluorohydrocarbon; a polymer with conductivity dopants; a conducting polymer, such as PEDOT/PSS; a self-assembly monomer derived from compounds such as phosphonic acid and silane derivatives; a metal oxide derivative, such as MoOx; a p-type semiconducting organic compound, such as 1,4,5,8,9,12-Hexaazatriphenylenehexacarbonitrile; a metal complex, and a cross-linkable compounds.


Examples of aromatic amine derivatives used in HIL or HTL include, but not limit to the following general structures:




embedded image


Each of Ar1 to Ar9 is selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Each Ar may be unsubstituted or may be substituted by a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.


In one aspect, Ar1 to Ar9 is independently selected from the group consisting of:




embedded image


wherein k is an integer from 1 to 20; X101 to X108 is C (including CH) or N; Z101 is NAr1, O, or S; Ar1 has the same group defined above.


Examples of metal complexes used in HIL or HTL include, but are not limited to the following general formula:




embedded image


wherein Met is a metal, which can have an atomic weight greater than 40; (Y101—Y102) is a bidentate ligand, Y101 and Y102 are independently selected from C, N, O, P, and S; L101 is an ancillary ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.


In one aspect, (Y101—Y102) is a 2-phenylpyridine derivative. In another aspect, (Y101—Y102) is a carbene ligand. In another aspect, Met is selected from Ir, Pt, Os, and Zn. In a further aspect, the metal complex has a smallest oxidation potential in solution vs. Fc+/Fc couple less than about 0.6 V.


Non-limiting examples of the HIL and HTL materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN102702075, DE102012005215, EP01624500, EP01698613, EP01806334, EP01930964, EP01972613, EP01997799, EP02011790, EP02055700, EP02055701, EP1725079, EP2085382, EP2660300, EP650955, JP07-073529, JP2005112765, JP2007091719, JP2008021687, JP2014-009196, KR20110088898, KR20130077473, TW201139402, U.S. Ser. No. 06/517,957, US20020158242, US20030162053, US20050123751, US20060182993, US20060240279, US20070145888, US20070181874, US20070278938, US20080014464, US20080091025, US20080106190, US20080124572, US20080145707, US20080220265, US20080233434, US20080303417, US2008107919, US20090115320, US20090167161, US2009066235, US2011007385, US20110163302, US2011240968, US2011278551, US2012205642, US2013241401, US20140117329, US2014183517, U.S. Pat. Nos. 5,061,569, 5,639,914, WO05075451, WO07125714, WO08023550, WO08023759, WO2009145016, WO2010061824, WO2011075644, WO2012177006, WO2013018530, WO2013039073, WO2013087142, WO2013118812, WO2013120577, WO2013157367, WO2013175747, WO2014002873, WO2014015935, WO2014015937, WO2014030872, WO2014030921, WO2014034791, WO2014104514, WO2014157018.




embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


EBL:

An electron blocking layer (EBL) may be used to reduce the number of electrons and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies, and or longer lifetime, as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than the emitter closest to the EBL interface. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and or higher triplet energy than one or more of the hosts closest to the EBL interface. In one aspect, the compound used in EBL contains the same molecule or the same functional groups used as one of the hosts described below.


Host:

The light emitting layer of the organic EL device of the present invention preferably contains at least a metal complex as light emitting material, and may contain a host material using the metal complex as a dopant material. Examples of the host material are not particularly limited, and any metal complexes or organic compounds may be used as long as the triplet energy of the host is larger than that of the dopant. Any host material may be used with any dopant so long as the triplet criteria is satisfied.


Examples of metal complexes used as host are preferred to have the following general formula:




embedded image


wherein Met is a metal; (Y103—Y104) is a bidentate ligand, Y103 and Y104 are independently selected from C, N, O, P, and S; L101 is an another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.


In one aspect, the metal complexes are:




embedded image


wherein (O—N) is a bidentate ligand, having metal coordinated to atoms O and N.


In another aspect, Met is selected from Ir and Pt. In a further aspect, (Y103—Y104) is a carbene ligand.


Examples of other organic compounds used as host are selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Each option within each group may be unsubstituted or may be substituted by a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.


In one aspect, the host compound contains at least one of the following groups in the molecule:




embedded image


embedded image


wherein each of R101 to R107 is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. k is an integer from 0 to 20 or 1 to 20; k′″ is an integer from 0 to 20. X101 to X108 is selected from C (including CH) or N. Z101 and Z102 is selected from NR101, O, or S.


Non-limiting examples of the host materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials:


EP2034538, EP2034538A, EP2757608, JP2007254297, KR20100079458, KR20120088644, KR20120129733, KR20130115564, TW201329200, US20030175553, US20050238919, US20060280965, US20090017330, US20090030202, US20090167162, US20090302743, US20090309488, US20100012931, US20100084966, US20100187984, US2010187984, US2012075273, US2012126221, US2013009543, US2013105787, US2013175519, US2014001446, US20140183503, US20140225088, US2014034914, U.S. Pat. No. 7,154,114, WO2001039234, WO2004093207, WO2005014551, WO2005089025, WO2006072002, WO2006114966, WO2007063754, WO2008056746, WO2009003898, WO2009021126, WO2009063833, WO2009066778, WO2009066779, WO2009086028, WO2010056066, WO2010107244, WO2011081423, WO2011081431, WO2011086863, WO2012128298, WO2012133644, WO2012133649, WO2013024872, WO2013035275, WO2013081315, WO2013191404, WO2014142472.




embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


Additional Emitters:

One or more additional emitter dopants may be used in conjunction with the compound of the present disclosure. Examples of the additional emitter dopants are not particularly limited, and any compounds may be used as long as the compounds are typically used as emitter materials. Examples of suitable emitter materials include, but are not limited to, compounds which can produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence, i.e., TADF (also referred to as E-type delayed fluorescence), triplet-triplet annihilation, or combinations of these processes.


Non-limiting examples of the emitter materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN103694277, CN1696137, EB01238981, EP01239526, EP01961743, EP1239526, EP1244155, EP1642951, EP1647554, EP1841834, EP1841834B, EP2062907, EP2730583, JP2012074444, JP2013110263, JP4478555, KR1020090133652, KR20120032054, KR20130043460, TW201332980, U.S. Ser. No. 06/699,599, U.S. Ser. No. 06/916,554, US20010019782, US20020034656, US20030068526, US20030072964, US20030138657, US20050123788, US20050244673, US2005123791, US2005260449, US20060008670, US20060065890, US20060127696, US20060134459, US20060134462, US20060202194, US20060251923, US20070034863, US20070087321, US20070103060, US20070111026, US20070190359, US20070231600, US2007034863, US2007104979, US2007104980, US2007138437, US2007224450, US2007278936, US20080020237, US20080233410, US20080261076, US20080297033, US200805851, US2008161567, US2008210930, US20090039776, US20090108737, US20090115322, US20090179555, US2009085476, US2009104472, US20100090591, US20100148663, US20100244004, US20100295032, US2010102716, US2010105902, US2010244004, US2010270916, US20110057559, US20110108822, US20110204333, US2011215710, US2011227049, US2011285275, US2012292601, US20130146848, US2013033172, US2013165653, US2013181190, US2013334521, US20140246656, US2014103305, U.S. Pat. Nos. 6,303,238, 6,413,656, 6,653,654, 6,670,645, 6,687,266, 6,835,469, 6,921,915, 7,279,704, 7,332,232, 7,378,162, 7,534,505, 7,675,228, 7,728,137, 7,740,957, 7,759,489, 7,951,947, 8,067,099, 8,592,586, 8,871,361, WO06081973, WO06121811, WO07018067, WO07108362, WO07115970, WO07115981, WO08035571, WO2002015645, WO2003040257, WO2005019373, WO2006056418, WO2008054584, WO2008078800, WO2008096609, WO2008101842, WO2009000673, WO2009050281, WO2009100991, WO2010028151, WO2010054731, WO2010086089, WO2010118029, WO2011044988, WO2011051404, WO2011107491, WO2012020327, WO2012163471, WO2013094620, WO2013107487, WO2013174471, WO2014007565, WO2014008982, WO2014023377, WO2014024131, WO2014031977, WO2014038456, WO2014112450.




embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


HBL:

A hole blocking layer (HBL) may be used to reduce the number of holes and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies and/or longer lifetime as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and or higher triplet energy than the emitter closest to the HBL interface. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and or higher triplet energy than one or more of the hosts closest to the HBL interface.


In one aspect, compound used in HBL contains the same molecule or the same functional groups used as host described above.


In another aspect, compound used in HBL contains at least one of the following groups in the molecule:




embedded image


wherein k is an integer from 1 to 20; L101 is an another ligand, k′ is an integer from 1 to 3.


ETL:

Electron transport layer (ETL) may include a material capable of transporting electrons. Electron transport layer may be intrinsic (undoped), or doped. Doping may be used to enhance conductivity. Examples of the ETL material are not particularly limited, and any metal complexes or organic compounds may be used as long as they are typically used to transport electrons.


In one aspect, compound used in ETL contains at least one of the following groups in the molecule:




embedded image


wherein R101 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. Ar1 to Ar3 has the similar definition as Ar's mentioned above. k is an integer from 1 to 20. X101 to X108 is selected from C (including CH) or N.


In another aspect, the metal complexes used in ETL contains, but not limit to the following general formula:




embedded image


wherein (O—N) or (N—N) is a bidentate ligand, having metal coordinated to atoms O, N or N, N; L101 is another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal.


Non-limiting examples of the ETL materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN103508940, EP01602648, EP01734038, EP01956007, JP2004-022334, JP2005149918, JP2005-268199, KR0117693, KR20130108183, US20040036077, US20070104977, US2007018155, US20090101870, US20090115316, US20090140637, US20090179554, US2009218940, US2010108990, US2011156017, US2011210320, US2012193612, US2012214993, US2014014925, US2014014927, US20140284580, U.S. Pat. Nos. 6,656,612, 8,415,031, WO2003060956, WO2007111263, WO2009148269, WO2010067894, WO2010072300, WO2011074770, WO2011105373, WO2013079217, WO2013145667, WO2013180376, WO2014104499, WO2014104535.




embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


In tandem or stacked OLEDs, the CGL plays an essential role in the performance, which is composed of an n-doped layer and a p-doped layer for injection of electrons and holes, respectively. Electrons and holes are supplied from the CGL and electrodes. The consumed electrons and holes in the CGL are refilled by the electrons and holes injected from the cathode and anode, respectively; then, the bipolar currents reach a steady state gradually. Typical CGL materials include n and p conductivity dopants used in the transport layers.


In any above-mentioned compounds used in each layer of the OLED device, the hydrogen atoms can be partially or fully deuterated. Thus, any specifically listed substituent, such as, without limitation, methyl, phenyl, pyridyl, etc. may be undeuterated, partially deuterated, and fully deuterated versions thereof. Similarly, classes of substituents such as, without limitation, alkyl, aryl, cycloalkyl, heteroaryl, etc. also may be undeuterated, partially deuterated, and fully deuterated versions thereof.


EXPERIMENTAL
Materials Synthesis

All reactions were carried out under nitrogen protections unless specified otherwise. All solvents for reactions are anhydrous and used as received from commercial sources.


Synthesis of Comparative Compound 1



embedded image


Iridium intermediate (1.10 g, 1.48 mmol), 2,4-bis(4-(tert-butyl)phenyl)-6-(6-phenylpyridin-3-yl)-1,3,5-triazine (2.22 g, 4.45 mmol), and Ethanol (30 mL) were combined in a flask with reflux condenser. The reaction was heated to reflux under an atmosphere of nitrogen and monitored by HPLC. After 96 hours, the reaction was cooled to room temperature and filtered over Celite. The solid thus collected was washed with MeOH, and then extracted with DCM. The crude product was purified via column chromatography using 60-75% Toluene:heptanes solvent system. The product was further purified by dissolving in DCM and precipitating with MeOH. The title compound was afforded (0.4 g, 26% yield) as a red powder.


Synthesis of Compound B-1074



embedded image


Iridium intermediate (1.50 g, 2.02 mmol), 2,4-diisopropyl-6-(6-phenylpyridin-3-yl)-1,3,5-triazine (1.93 g, 6.05 mmol) and ethanol (40 mL) were combined in a flask. A condenser was attached then the system was placed under nitrogen. The reaction was heated to reflux overnight. Upon cooling down to room temperature, solid crashed out and was filtered over a pad of Celite and washed with MeOH. The solids were then was washed with DCM. The crude product was purified via column chromatography using heptanes/DCM/EA (79/20/1) solvent system. The product was triturated from MeOH to afford 1.40 g (82% yield) of the title compound.


Synthesis of Compound B-1079



embedded image


rIridium intermediate (1.80 g, 2.42 mmol), 2,4-di-tert-butyl-6-(6-phenylpyridin-3-yl)-1,3,5-triazine (2.52 g, 7.26 mmol) and ethanol (50 mL) were combined in a flask. A condenser was attached then the system was placed under nitrogen. The reaction was heated to reflux overnight. Upon cooling down to room temperature, solid crashed out and was filtered over a pad of Celite and washed with MeOH. The solids were then washed with DCM. The product was purified via column chromatography using toluene/heptanes (80/20) solvent system. The product was then triturated from MeOH to afford the title compound (1.40 g, 66% yield).


Synthesis of Compound B-115,515



embedded image


Iridium intermediate (1.40 g, 1.79 mmol), 2,4-di-tert-butyl-6-(6-phenylpyridin-3-yl)-1,3,5-triazine (1.86 g, 5.37 mmol) and ethanol (36 mL) were combined in a flask with a reflux condenser. The reaction was heated to reflux overnight. Upon cooling down to room temperature, solid crashed out and was filtered over a pad of Celite and washed with MeOH. The solids were then washed with DCM. The crude product was purified via column chromatography using toluene/heptanes (60/40) solvent system. The product was then triturated from MeOH to afford the title compound (0.50 g, 30% yield).


All example devices were fabricated by high vacuum (<10−7 Torr) thermal evaporation. The anode electrode was 1150 Å of indium tin oxide (ITO). The cathode consisted of 10 Å of Liq (8-hydroxyquinoline lithium) followed by 1,000 Å of Al. All devices were encapsulated with a glass lid sealed with an epoxy resin in a nitrogen glove box (<1 ppm of H2O and O2) immediately after fabrication, and a moisture getter was incorporated inside the package. The organic stack of the device examples consisted of sequentially, from the ITO surface, 100 Å of LG101(purchased from LG chem) as the hole injection layer (HIL); 400 Å of HTM as a hole transporting layer (HTL); 300 Å of an emissive layer (EML) containing Compound H as a host, a stability dopant (SD) (18%), and Comparative Compound 1 or Compounds 1074, 1079, and 3223 as the emitter (3%); 100 Å of Compound H as a blocking layer; and 350 Å of Liq (8-hydroxyquinoline lithium) doped with 40% of ETM as the ETL. The emitter was selected to provide the desired color, efficiency and lifetime. The stability dopant (SD) was added to the electron-transporting host to help transport positive charge in the emissive layer. The Comparative Example device was fabricated similarly to the device examples except that Comparative Compound 1 was used as the emitter in the EML. FIG. 1 shows the schematic device structure. Table 1 shows the device layer thickness and materials. The chemical structures of the materials used in the devices are shown below:




embedded image


embedded image


embedded image


The device performance data are summarized in Table 2. The comparative compound has a very high sublimation temperature (TSUB) and partially decomposed during thermal evaporation, which does not make it a suitable material for commercial applications. Compounds B-1074, B-1079, and B-115,515 all have much lower sublimation temperature which makes them much easier to manufacture. Moreover, the inventive compounds showed very similar color (λ max from 598 to 603 nm) and Full Width at Half Maximum (FWHM) from 80 to 82 nm. They also showed high EQE and long lifetime.









TABLE 1







Device layer materials and thicknesses











Layer
Material
Thickness [Å]















Anode
ITO
1150



HIL
LG101 (LG Chem)
100



HTL
HTM
400



EML
Compound H: SD
300




18%:Emitter 3%




BL
Compound H
100



ETL
Liq: ETM 40%
350



EIL
Liq
10



Cathode
Al
1000

















TABLE 2







Device performance data




















At 10 mA/cm2
At 80 mA/cm2


Device

TSUB
1931 CIE
λ max
FWHM
EQE
LT95%















Example
Emitter
[° C.]
x
y
[nm]
[nm]
[%]
[h]





Example 1
Compound B-
192
0.607
0.391
599
80
18.5
5,400



1074









Example 2
Compound B-
204
0.606
0.391
598
81
18.4
4,300



1079









Example 3
Compound B-
197
0.616
0.383
603
82
20.1
18,300 



114,979









CE1
Comparative
287









Compound 1









It is understood that the various embodiments described herein are by way of example only, and are not intended to limit the scope of the invention. For example, many of the materials and structures described herein may be substituted with other materials and structures without deviating from the spirit of the invention. The present invention as claimed may therefore include variations from the particular examples and preferred embodiments described herein, as will be apparent to one of skill in the art. It is understood that various theories as to why the invention works are not intended to be limiting.

Claims
  • 1. A heteroleptic compound having a formula Ir(LA)n(LB)3−n: wherein the ligand LA is
  • 2. The compound of claim 1, wherein ring A is benzene.
  • 3. The compound of claim 1, wherein ring C is benzene, and ring D is pyridine of which X5 is N.
  • 4. The compound of claim 1, wherein X1, X2, X3, and X4 are each a carbon.
  • 5. The compound of claim 1, wherein RB is para or meta to the N coordinated to Ir.
  • 6. The compound of claim 1, wherein at least one of R1 and R2 is selected from the group consisting of:
  • 7. The compound of claim 1, wherein the ligand LA is selected from the group consisting of LA1 through LA268 defined below:
  • 8. The compound of claim 1, wherein the ligand LB is selected from the group consisting of:
  • 9. The compound of claim 8, wherein the ligand LB is selected from the group consisting of:
  • 10. The compound of claim 8, wherein the ligand LB is selected from the group consisting of:
  • 11. The compound of claim 8, wherein the ligand LB is selected from the group consisting of LC1 through LC856 each of which has the structure of
  • 12. The compound of claim 11, wherein the compound is selected from the group consisting of Compound A-1 through Compound A-4556 and Compound B-1 through Compound B-229,408; wherein each Compound A-x has the formula Ir(LAi)2(LBj);wherein x=268j+i−268, i is an integer from 1 to 268, and j is an integer from 1 to 17;where each Compound B-y has the formula Ir(LAi)(LCk)2;wherein y=268k+i−268, i is an integer from 1 to 268, and k is an integer from 1 to 856; wherein LAi has the following structure:
  • 13. A first organic light emitting device comprising: an anode;a cathode; andan organic layer, disposed between the anode and the cathode, comprising a heteroleptic compound having a formula Ir(LA)n(LB)3−n:wherein the ligand LA is
  • 14. The first organic light emitting device of claim 13, wherein the first organic light emitting device is incorporated into a device selected from the group consisting of a consumer product, an electronic component module, an organic light-emitting device, and a lighting panel.
  • 15. The first organic light emitting device of claim 13, wherein the organic layer is an emissive layer and the compound is an emissive dopant or a non-emissive dopant.
  • 16. The first organic light emitting device of claim 13, wherein the organic layer further comprises a host, wherein the host comprises a triphenylene containing benzo-fused thiophene or benzo-fused furan; wherein any substituent in the host is an unfused substituent independently selected from the group consisting of CnH2n+1, OCnH2n+1, OAr1, N(CnH2n+1)2, N(Ar1)(Ar2), CH═CH—CnH2n+1, C≡C—CnH2n+1, Ar1, Ar1—Ar2, and CnH2n—Ar1, or the host has no substitutions;wherein n is from 1 to 10; andwherein Ar1 and Ar2 are independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof.
  • 17. The first organic light emitting device of claim 13, wherein the organic layer further comprises a host, wherein host comprises at least one chemical group selected from the group consisting of carbazole, dibenzothiphene, dibenzofuran, dibenzoselenophene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene.
  • 18. The first organic light emitting device of claim 13, wherein the organic layer further comprises a host, wherein the host is selected from the group consisting of:
  • 19. The first organic light emitting device of claim 13, wherein the organic layer further comprises a host, wherein the host comprises a metal complex.
  • 20. A formulation comprising a heteroleptic compound having a formula Ir(LA)n(LB)3−n: wherein the ligand LA is
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/141,939, filed Apr. 29, 2016, which claims priority under 35 U.S.C. § 119(e)(1) to U.S. Patent Application Ser. No. 62/171,005, filed on Jun. 4, 2015, the entire contents of which are incorporated herein by reference.

Provisional Applications (1)
Number Date Country
62171005 Jun 2015 US
Continuations (1)
Number Date Country
Parent 15141939 Apr 2016 US
Child 18439014 US